JavaScript NENÍ povolen !

Calkins H, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816–861. PubMed

Calkins H, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9(4):632–696.e21. PubMed

Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(13):1373–1384. PubMed

Anderson JL. Evolution of the ACC/AHA clinical practice guidelines in perspective: guiding the guidelines. J Am Coll Cardiol. 2015;65(25):2735–2738. PubMed

January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76. PubMed

Kirchhof P, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1–e88. PubMed

Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace. 2010;12(10):1360–1420. PubMed

Lloyd-Jones DM, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042–1046. PubMed

Benjamin EJ, et al. Independent risk factors for atrial fibrillation in a populationbased cohort: The Framingham Heart Study. JAMA. 1994;271(11):840–844. PubMed

Miller JD, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol. 2015;66(25):2899–2906. PubMed

EHRA Scientific Committee Task Force, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) Europace. 2017;19(2):190–225. PubMed PMC

Allan V, et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost. 2017;117(5):837–850. PubMed PMC

de Vos CB, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55(8):725–731. PubMed

Wijffels MC, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–1968. PubMed

Walters TE, et al. Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative intervention. Heart Rhythm. 2016;13(2):331–339. PubMed

Wakili R, et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011;121(8):2955–2968. PubMed PMC

Heijman J, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014;114(9):1483–1499. PubMed

Kopecky SL, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987;317(11):669–674. PubMed

Kochhauser S, et al. Predictors for progression of atrial fibrillation in patients awaiting atrial fibrillation ablation. Can J Cardiol. 2016;32(11):1348–1354. PubMed

Sugihara C, et al. The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF. Europace. 2015;17(6):864–870. PubMed

Fox CS, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004;291(23):2851–2855. PubMed

Arnar DO, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006;27(6):708–712. PubMed

Lubitz SA, et al. Association between familial atrial fibrillation and risk of newonset atrial fibrillation. JAMA. 2010;304(20):2263–2269. PubMed PMC

Christophersen IE, Ellinor PT. Genetics of atrial fibrillation: from families to genomes. J Hum Genet. 2016;61(1):61–70. PubMed

Gudbjartsson DF, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448(7151):353–357. PubMed

Benjamin EJ, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41(8):879–881. PubMed PMC

Gudbjartsson DF, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;41(8):876–878. PubMed PMC

Ellinor PT, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42(3):240–244. PubMed PMC

Ellinor PT, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44(6):670–675. PubMed PMC

Sinner MF, et al. Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation. 2014;130(15):1225–1235. PubMed PMC

Lubitz SA, et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014;63(12):1200–1210. PubMed PMC

Tada H, et al. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke. Stroke. 2014;45(10):2856–2862. PubMed PMC

Everett BM, et al. Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J. 2013;34(29):2243–2251. PubMed PMC

Lubitz SA, et al. Genetic risk prediction of atrial fibrillation. Circulation. 2017;135(14):1311–1320. PubMed PMC

Hucker WJ, et al. Atrial fibrillation genetics: is there a practical clinical value now or in the future? Can J Cardiol. 2016;32(11):1300–1305. PubMed PMC

Shoemaker MB, et al. Common genetic variants and response to atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2015;8(2):296–302. PubMed PMC

Choi EK, et al. Korean Atrial Fibrillation (AF) Network: genetic variants for AF do not predict ablation success. J Am Heart Assoc. 2015;4(8):e002046. PubMed PMC

Chugh SS, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847. PubMed PMC

Colilla S, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147. PubMed

Kannel WB, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N–9N. PubMed

Miller PS, Andersson FL, Kalra L. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated? Stroke. 2005;36(2):360–366. PubMed

Miyasaka Y, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49(9):986–992. PubMed

Chen LY, Benditt DG, Alonso A. Atrial fibrillation and its association with sudden cardiac death. Circ J. 2014;78(11):2588–2593. PubMed

Lubitz SA, et al. Atrial fibrillation patterns and risks of subsequent stroke, HF, or death in the community. J Am Heart Assoc. 2013;2(5):e000126. PubMed PMC

Wang TJ, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920–2925. PubMed

Jacobs V, et al. Atrial fibrillation and dementia. Trends Cardiovasc Med. 2015;25(1):44–51. PubMed

Dorian P, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36(4):1303–1309. PubMed

Boriani G, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015;128(5):509–518.e2. PubMed

Kim MH, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(3):313–320. PubMed

Go AS, et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410. PubMed

Ganesan AN, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591–1602. PubMed

Van Gelder IC, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347(23):1834–1840. PubMed

Wyse DG, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–1833. PubMed

Carlsson J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 2003;41(10):1690–1696. PubMed

Roy D, et al. Rhythm control versus rate control for atrial fibrillation and HF. N Engl J Med. 2008;358(25):2667–2677. PubMed

Hindricks G, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005;112(3):307–313. PubMed

Vasamreddy CR, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006;17(2):134–139. PubMed

Verma A, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. 2013;173(2):149–156. PubMed

Rienstra M, et al. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study. Heart Rhythm. 2014;11(6):939–945. PubMed

Siontis KC, et al. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications. Heart Rhythm. 2016;13(7):1418–1424. PubMed PMC

Reynolds MR, et al. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart J. 2006;152(6):1097–1103. PubMed PMC

Pedrote A, et al. Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor. J Cardiovasc Electrophysiol. 2013;24(10):1075–1082. PubMed

Wokhlu A, et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol. 2010;55(21):2308–2316. PubMed

Ho SY, et al. Anatomy of the LA: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10(11):1525–1533. PubMed

Ho SY, McCarthy KP. Anatomy of the left atrium for interventional electrophysiologists. Pacing Clin Electrophysiol. 2010;33(5):620–627. PubMed

Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol. 2012;5(1):220–228. PubMed

Kato R, et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation. 2003;107(15):2004–2010. PubMed

Jongbloed MR, et al. Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol. 2005;45(5):749–753. PubMed

Mlcochova H, et al. Magnetic resonance angiography of pulmonary veins: implications for catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2005;28(10):1073–1080. PubMed

Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation. 1966;34(3):412–422. PubMed

Weiss C, et al. Impact of the distribution and structure of myocardium in the pulmonary veins for radiofrequency ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2002;25(9):1352–1356. PubMed

Wang K, et al. Architecture of atrial musculature in humans. Br Heart J. 1995;73(6):559–565. PubMed PMC

Anne W, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005;67(4):655–666. PubMed

Goette A, Rocken C. Atrial amyloidosis and atrial fibrillation: a gender-dependent “arrhythmogenic substrate”? Eur Heart J. 2004;25(14):1185–1186. PubMed

Pashakhanloo F, et al. Myofiber Architecture of the Human Atria as Revealed by Submillimeter Diffusion Tensor Imaging. Circ Arrhythm Electrophysiol. 2016;9(4):e004133. PubMed PMC

Hansen BJ, et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J. 2015;36(35):2390–2401. PubMed PMC

Haissaguerre M, et al. Intermittent drivers anchoring to structural heterogeneities as a major pathophysiological mechanism of human persistent atrial fibrillation. J Physiol. 2016;594(9):2387–2398. PubMed PMC

Kim DT, et al. The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol. 2000;36(4):1324–1327. PubMed

Han S, et al. Electrophysiological characteristics of the Marshall bundle in humans. Heart Rhythm. 2010;7(6):786–793. PubMed PMC

Cabrera JA, et al. The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J. 2008;29(3):356–362. PubMed

Gittenberger-de Groot AC, et al. The role of neural crest and epicardium-derived cells in conduction system formation. Novartis Found Symp. 2003;250:125–134. discussion 134-41, 276-9. PubMed

Jongbloed MR, et al. Embryonic conduction tissue: a spatial correlation with adult arrhythmogenic areas. J Cardiovasc Electrophysiol. 2004;15(3):349–355. PubMed

Perez-Lugones A, et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(8):803–809. PubMed

Ehrlich JR, et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol. 2003;551(Pt 3):801–813. PubMed PMC

Chen YC, et al. Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes. J Cardiovasc Electrophysiol. 2009;20(9):1039–1045. PubMed

Verheule S, et al. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res. 2002;55(4):727–738. PubMed

Honjo H, et al. Pacing-induced spontaneous activity inmyocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation. 2003;107(14):1937–1943. PubMed

Levin MD, et al. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J Clin Invest. 2009;119(11):3420–3436. PubMed PMC

Wongcharoen W, et al. Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardiovasc Res. 2006;70(3):497–508. PubMed

Weerasooriya R, et al. Dissociated pulmonary vein arrhythmia: incidence and characteristics. J Cardiovasc Electrophysiol. 2003;14(11):1173–1179. PubMed

Hocini M, et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation. 2002;105(20):2442–2448. PubMed

Arora R, et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation. 2003;107(13):1816–1821. PubMed PMC

Ozgen N, et al. Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. Cardiovasc Res. 2007;75(4):758–769. PubMed PMC

Kalifa J, et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation. 2003;108(6):668–671. PubMed

Jais P, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation. 2002;106(19):2479–2485. PubMed

Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol. 2005;16(2):229–232. PubMed

Kumagai K, et al. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol. 2004;43(12):2281–2289. PubMed

Sanders P, et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation. 2005;112(6):789–797. PubMed

Atienza F, et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation. 2006;114(23):2434–2442. PubMed

Hou Y, Zhou Q, Po SS. Neuromodulation for cardiac arrhythmia. Heart Rhythm. 2016;13(2):584–592. PubMed

Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation. 1997;95(11):2573–2584. PubMed

Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl) 2005;209(6):425–438. PubMed

Armour JA, et al. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247(2):289–298. PubMed

Pauza DH, Skripka V, Pauziene N. Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histochemical staining with acetylcholinesterase. Cells Tissues Organs. 2002;172(4):297–320. PubMed

Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(10):1186–1189. PubMed

Hou Y, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol. 2007;50(1):61–68. PubMed

Chevalier P, et al. Quantitative study of nerves of the human LA. Heart Rhythm. 2005;2(5):518–522. PubMed

Tan AY, et al. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J Am Coll Cardiol. 2006;48(1):132–143. PubMed

Chen PS, et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500–1515. PubMed PMC

Scherlag BJ, et al. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol. 2005;45(11):1878–1886. PubMed

Po SS, et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006;3(2):201–208. PubMed

Jayachandran JV, et al. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation. 2000;101(10):1185–1191. PubMed

Lu Z, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1(3):184–192. PubMed PMC

Patterson E, et al. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2(6):624–631. PubMed

Zhou J, et al. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol. 2007;18(1):83–90. PubMed

Choi EK, et al. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs. Circulation. 2010;121(24):2615–2623. PubMed PMC

Lemery R, et al. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm. 2006;3(4):387–396. PubMed

Scanavacca M, et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation. 2006;114(9):876–885. PubMed

Katritsis D, et al. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 2008;102(3):330–334. PubMed

Pokushalov E, et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6(9):1257–1264. PubMed

Katritsis DG, et al. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8(5):672–678. PubMed

Katritsis DG, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62(24):2318–2325. PubMed

Driessen AH, et al. Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study. J Am Coll Cardiol. 2016;68(11):1155–1165. PubMed

Nakagawa H, et al. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6(12 Suppl):S26–S34. PubMed

Chen J, Wasmund SL, Hamdan MH. Back to the future: the role of the autonomic nervous system in atrial fibrillation. Pacing Clin Electrophysiol. 2006;29(4):413–421. PubMed

Bauer A, et al. Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm. 2006;3(12):1428–1435. PubMed

Pokushalov E, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60(13):1163–1170. PubMed

Pokushalov E, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study. Circ Arrhythm Electrophysiol. 2015;8(6):1334–1341. PubMed

Tsai WC, et al. Effects of renal sympathetic denervation on the stellate ganglion and brain stem in dogs. Heart Rhythm. 2017;14(2):255–262. PubMed PMC

Mahnkopf C, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7(10):1475–1481. PubMed PMC

Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol. 2012;23(7):797–799. PubMed

Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013;34(35):2731–2738. PubMed

Cochet H, et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015;26(5):484–492. PubMed

Chrispin J, et al. Clinical predictors of cardiac magnetic resonance late gadolinium enhancement in patients with atrial fibrillation. Europace. 2017;19(3):371–377. PubMed PMC

Konrad T, et al. Primary persistent atrial fibrillation: a distinct arrhythmia subentity of an ablation population. J Cardiovasc Electrophysiol. 2015;26(12):1289–1294. PubMed

Boldt A, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004;90(4):400–405. PubMed PMC

de Oliveira IM, et al. Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. Cardiovasc Pathol. 2013;22(1):65–69. PubMed

Smorodinova N, et al. Bioptic study of left and right atrial interstitium in cardiac patients with and without atrial fibrillation: interatrial but not rhythm-based differences. PLoS One. 2015;10(6):e0129124. PubMed PMC

Platonov PG, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58(21):2225–2232. PubMed

Kottkamp H, et al. Box Isolation of Fibrotic Areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):22–30. PubMed

Andrade J, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453–1468. PubMed

Andrade JG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol. 2014;7(1):69–75. PubMed

Andrade J, et al. The time course of exit and entrance block during cryoballoon pulmonary vein isolation. Europace. 2014;16(4):500–504. PubMed

Swartz MF, et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol. 2012;60(18):1799–1806. PubMed PMC

Akoum N, et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol. 2012;23(1):44–50. PubMed PMC

Kottkamp H, Schreiber D. The Substrate in “Early Persistent” Atrial Fibrillation: Arrhythmia Induced, Risk Factor Induced, or From a Specific Fibrotic Atrial Cardiomyopathy? JACC: Clinical Electrophysiology. 2016;2(2):140–142. PubMed

Jalife J, et al. Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? J Cardiovasc Electrophysiol. 1998;9(8 Suppl):S2–S12. PubMed

Goette A, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18(10):1455–1490. PubMed PMC

Nattel S, et al. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005;48(1):9–28. PubMed

Potpara TS, et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. Chest. 2012;141(2):339–347. PubMed

Holmqvist F, et al. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart. 2015;101(11):894–899. PubMed PMC

Veasey RA, et al. The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease? J Interv Card Electrophysiol. 2015;44(1):23–30. PubMed

Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230–246. PubMed

Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1(1):62–73. PubMed

Filgueiras-Rama D, et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the LA. Circ Arrhythm Electrophysiol. 2012;5(6):1160–1167. PubMed PMC

Pandit SV, Jalife J. Rotors and the dynamics of cardiac fibrillation. Circ Res. 2013;112(5):849–862. PubMed PMC

Nattel S. Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms. Can J Cardiol. 2013;29(10):1147–1149. PubMed

Martins RP, et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014;129(14):1472–1482. PubMed PMC

Wei SK, et al. Muscarinic modulation of the sodium-calcium exchanger in HF. Circulation. 2007;115(10):1225–1233. PubMed

Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J. 2012;33(15):1870–1877. PubMed

Corradi D. Atrial fibrillation from the pathologist’s perspective. Cardiovasc Pathol. 2014;23(2):71–84. PubMed

Pinho-Gomes AC, et al. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal. 2014;20(8):1268–1285. PubMed PMC

Deshmukh A, et al. Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence. Circ Arrhythm Electrophysiol. 2015;8(1):32–41. PubMed PMC

Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35(2):83–92. PubMed

He X, et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res. 2011;108(2):164–175. PubMed PMC

Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335–2345. PubMed

Ben Amar M, Bianca C. Towards a unified approach in the modeling of fibrosis: A review with research perspectives. Phys Life Rev. 2016;17:61–85. PubMed

Jalife J. Mechanisms of persistent atrial fibrillation. Curr Opin Cardiol. 2014;29(1):20–27. PubMed

Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25(6):475–484. PubMed PMC

de Bakker JM, et al. Slow conduction in the infarcted human heart ‘Zigzag’ course of activation. Circulation. 1993;88(3):915–926. PubMed

Bian W, Tung L. Structure-related initiation of reentry by rapid pacing in monolayers of cardiac cells. Circ Res. 2006;98(4):e29–e38. PubMed

Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 1997;20(2 Pt 2):397–413. PubMed

de Bakker JM, Stein M, van Rijen HV. Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation. Heart Rhythm. 2005;2(7):777–779. PubMed

Valderrabano M, et al. Obstacle-induced transition from ventricular fibrillation to tachycardia in isolated swine right ventricles: insights into the transition dynamics and implications for the critical mass. J Am Coll Cardiol. 2000;36(6):2000–2008. PubMed

Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol. 2005;14(1):37–41. PubMed

Roberts-Thomson KC, Sanders P, Kalman JM. Sinus node disease: an idiopathic right atrial myopathy. Trends Cardiovasc Med. 2007;17(6):211–214. PubMed

Haemers P, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38(1):53–61. PubMed

Pathak RK, et al. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31(2):203–210. PubMed

Nalliah CJ, et al. The role of obesity in atrial fibrillation. Eur Heart J. 2016;37(20):1565–1572. PubMed

Mahajan R, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66(1):1–11. PubMed

Rocken C, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 2002;106(16):2091–2097. PubMed

Podduturi V, et al. Isolated atrial amyloidosis and the importance of molecular classification. Proc (Bayl Univ Med Cent) 2013;26(4):387–389. PubMed PMC

Hove-Madsen L, et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation. 2004;110(11):1358–1363. PubMed

Wang L, et al. Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation. Circ Res. 2014;114(9):1410–1421. PubMed PMC

Greiser M, Schotten U. Dynamic remodeling of intracellular Ca(2)(+) signaling during atrial fibrillation. J Mol Cell Cardiol. 2013;58:134–142. PubMed

Voigt N, et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation. 2012;125(17):2059–2070. PubMed PMC

Chiang DY, et al. Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release. Circ Arrhythm Electrophysiol. 2014;7(6):1214–1222. PubMed PMC

Li N, et al. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation. 2014;129(12):1276–1285. PubMed PMC

Dong LW, et al. Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. Shock. 2001;16(1):33–39. PubMed

Caballero R, et al. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both. J Am Coll Cardiol. 2010;55(21):2346–2354. PubMed

Van Wagoner DR, et al. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85(5):428–436. PubMed

Voigt N, et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(5):472–480. PubMed PMC

Nattel S. Changes in the atrial transcriptome and atrial fibrillation: susceptibility, persistence, causes, and consequences. Circ Arrhythm Electrophysiol. 2015;8(1):5–7. PubMed

Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res. 2002;54(2):204–216. PubMed

Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415(6868):219–226. PubMed

Schotten U, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265–325. PubMed

Haissaguerre M, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–666. PubMed

Engelman TW. Ueber den Einfluss der Systole auf die motorische Leitung in der Herzkammer, mit Bemerkungen zur Theorie allorhythmischer Herzstörungen. Archiv für die gesamte Physiologie des Menschen und der Tiere. 1896;62(12):543–566.

Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964;67:200–220. PubMed

Garrey WE. The nature of fibrillary contraction of the heart. Its relation to tissue mass and form. Annals of Noninvasive Electrocardiology. 1998;3(2):163–180.

Jalife J. Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc Res. 2011;89(4):766–775. PubMed PMC

Lewis T. Oliver-Sharpey Lectures on the nature of flutter and fibrillation of the auricle. Br Med J. 1921;1(3146):551–555. PubMed PMC

de Boer RA, et al. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail. 2009;11(9):811–817. PubMed

Chen YJ, et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation. 2001;104(23):2849–2854. PubMed

Voigt N, et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation. 2014;129(2):145–156. PubMed PMC

Christ T, et al. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A. 2014;111(30):11193–11198. PubMed PMC

Greiser M, et al. Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest. 2014;124(11):4759–4772. PubMed PMC

Lee SH, et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation. J Am Coll Cardiol. 2005;46(6):1054–1059. PubMed

Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res. 1973;33(1):54–62. PubMed

Mines GR. On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. 1914

Wiener N, Rosenblueth A. The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle. Arch Inst Cardiol Mex. 1946;16(3):205–265. PubMed

Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The “leading circle” concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res. 1977;41(1):9–18. PubMed

Winfree AT. Varieties of spiral wave behavior: An experimentalist’s approach to the theory of excitable media. Chaos. 1991;1(3):303–334. PubMed

Rensma PL, et al. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res. 1988;62(2):395–410. PubMed

Winfree AT. Vortex action potentials in normal ventricular muscle. Ann N Y Acad Sci. 1990;591:190–207. PubMed

Davidenko JM, et al. Sustained vortex-like waves in normal isolated ventricular muscle. Proc Natl Acad Sci U S A. 1990;87(22):8785–8789. PubMed PMC

Jalife J, D M, Anumonwo J, Berenfeld O, Kalifa J. Basic Cardiac Electrophysiology for the Clinician. Armonk, NY: Futura Pub; 1999.

Fast VG, Kleber AG. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc Res. 1997;33(2):258–271. PubMed

Zhao J, et al. Integration of High-Resolution Optical Mapping and 3-Dimensional Micro-Computed Tomographic Imaging to Resolve the Structural Basis of Atrial Conduction in the Human Heart. Circ Arrhythm Electrophysiol. 2015;8(6):1514–1517. PubMed PMC

Kneller J, et al. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res. 2005;96(5):e35–e47. PubMed

Cuculich PS, et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation. 2010;122(14):1364–1372. PubMed PMC

Haissaguerre M, et al. Driver domains in persistent atrial fibrillation. Circulation. 2014;130(7):530–538. PubMed

Narayan SM, et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) J Am Coll Cardiol. 2014;63(17):1761–1768. PubMed PMC

Lin YJ, et al. Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(5):851–858. PubMed

Lin Y-J, et al. Benefits of atrial substrate modification guided by electrogram similarity and phase mapping techniques to eliminate rotors and focal sources versus conventional defragmentation in persistent atrial fibrillation. JACC: Clinical Electrophysiology. 2016;2(6):667–678. PubMed

Miller JM, et al. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol. 2014;25(9):921–929. PubMed PMC

Lee S, et al. Simultaneous biatrial high-density (510-512 electrodes) epicardial mapping of persistent and long-standing persistent atrial fibrillation in patients: new insights into the mechanism of its maintenance. Circulation. 2015;132(22):2108–2117. PubMed PMC

van der Does LJ, et al. Dynamics of endo- and epicardial focal fibrillation waves at the right atrium in a patient with advanced atrial remodelling. Can J Cardiol. 2016;32(10):1260.e19–1260.e21. PubMed

de Groot N, et al. Direct proof of endo-epicardial asynchrony of the atrial wall during atrial fibrillation in humans. Circ Arrhythm Electrophysiol. 2016;9(5) PubMed

Perez FJ, et al. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2(4):393–401. PubMed

Pappone C, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003;42(2):185–197. PubMed

Hsu LF, et al. Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004;109(7):828–832. PubMed

Chen MS, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol. 2004;43(6):1004–1009. PubMed

Gentlesk PJ, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(1):9–14. PubMed

Khan MN, et al. Pulmonary-vein isolation for atrial fibrillation in patients with HF. N Engl J Med. 2008;359(17):1778–1785. PubMed

MacDonald MR, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97(9):740–747. PubMed

Hunter RJ, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial) Circ Arrhythm Electrophysiol. 2014;7(1):31–38. PubMed

Themistoclakis S, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol. 2010;55(8):735–743. PubMed

Bunch TJ, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(8):839–845. PubMed

Dagres N, et al. Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail. 2011;17(11):964–970. PubMed

Lin YJ, et al. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace. 2013;15(5):676–684. PubMed

Ghanbari H, et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11(9):1503–1511. PubMed

Yaksh A, et al. Atrial fibrillation: to map or not to map? Neth Heart J. 2014;22(6):259–266. PubMed PMC

Pappone C, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation. 2000;102(21):2619–2628. PubMed

Verma A, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–1822. PubMed

Kottkamp H, et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J Am Coll Cardiol. 2004;44(4):869–877. PubMed

Pappone C, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004;109(3):327–334. PubMed

Byrd GD, et al. Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation. 2005;112(9 Suppl):I7–I13. PubMed

Tan AY, et al. Electrical connections between left superior pulmonary vein, LA, and ligament of Marshall: implications for mechanisms of atrial fibrillation. Am J Physiol Heart Circ Physiol. 2006;290(1):H312–H322. PubMed

Narayan SM, et al. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation) J Am Coll Cardiol. 2013;62(2):138–147. PubMed PMC

Gaita F, et al. Very long-term results of surgical and transcatheter ablation of long-standing persistent atrial fibrillation. Ann Thorac Surg. 2013;96(4):1273–1278. PubMed

Ganesan AN, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549. PubMed PMC

Oral H, et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol. 2002;40(1):100–104. PubMed

Joshi S, et al. Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings. J Cardiovasc Electrophysiol. 2009;20(10):1089–1094. PubMed

Andrade JG, et al. Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy. J Cardiovasc Electrophysiol. 2012;23(12):1295–1301. PubMed

Grubman E, et al. Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium. J Cardiovasc Electrophysiol. 1999;10(3):336–342. PubMed

Hsieh MH, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. Circulation. 1999;100(22):2237–2243. PubMed

Fenelon G, Brugada P. Delayed effects of radiofrequency energy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996;19(4 Pt 1):484–489. PubMed

Lodzinski P, et al. Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up. Cardiol J. 2014;21(4):384–391. PubMed

Liang JJ, et al. Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: Timing and frequency of early recurrences predicts long-term ablation success. Heart Rhythm. 2015;12(12):2461–2468. PubMed

Jais P, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498–2505. PubMed

Calkins H, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–361. PubMed

Verma A, et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation. 2005;112(5):627–635. PubMed

Eitel C, et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. Heart Rhythm. 2010;7(2):157–164. PubMed

Macle L, et al. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet. 2015;386(9994):672–679. PubMed

Ouyang F, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368–2377. PubMed

Weerasooriya R, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160–166. PubMed

Wokhlu A, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol. 2010;21(10):1071–1078. PubMed

Hsieh MH, et al. The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J Cardiovasc Electrophysiol. 2006;17(3):231–235. PubMed

Sotomi Y, et al. Cause of very late recurrence of atrial fibrillation or flutter after catheter ablation for atrial fibrillation. Am J Cardiol. 2013;111(4):552–556. PubMed

Mainigi SK, et al. Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol. 2007;18(1):69–74. PubMed

Gaztanaga L, et al. Time to recurrence of atrial fibrillation influences outcome following catheter ablation. Heart Rhythm. 2012;10(1):2–9. PubMed

January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–2104. PubMed

EHRA Scientific Committee Task Force, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation. Endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) Europace. 2016 Epub ahead of print. PubMed PMC

Dublin S, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166(21):2322–2328. PubMed

Gami AS, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571. PubMed

Tedrow UB, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women’s Health Study) J Am Coll Cardiol. 2010;55(21):2319–2327. PubMed PMC

Huxley RR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123(14):1501–1508. PubMed PMC

Munger TM, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60(9):851–860. PubMed

Abed HS, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90–100. PubMed

Richter B, et al. Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor? Eur Heart J. 2006;27(21):2553–2559. PubMed

Jongnarangsin K, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(7):668–672. PubMed

Shah AN, et al. Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol. 2008;19(7):661–667. PubMed

Chang SL, et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol. 2009;103(1):67–72. PubMed

Letsas KP, et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009;11(2):158–163. PubMed

Tang RB, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J. 2009;73(3):438–443. PubMed

Jin Hwang H, et al. Atrial electroanatomical remodeling as a determinant of different outcomes between two current ablation strategies: circumferential pulmonary vein isolation vs pulmonary vein isolation. Clin Cardiol. 2010;33(3):E69–E74. PubMed PMC

Patel D, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7(2):167–172. PubMed

Patel D, et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol. 2010;3(5):445–451. PubMed

Patel D, et al. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females. Europace. 2010;12(3):322–330. PubMed

Chao TF, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J. 2011;75(10):2326–2332. PubMed

Winkle RA, et al. Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes. Am J Cardiol. 2011;108(3):374–379. PubMed

Wong CX, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–1751. PubMed

Kang JH, et al. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. J Cardiovasc Electrophysiol. 2012;23(11):1165–1170. PubMed

Mohanty S, et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59(14):1295–1301. PubMed

Ejima K, et al. Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation. Int J Cardiol. 2013;164(1):88–93. PubMed

Letsas KP, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol. 2013;164(1):94–98. PubMed

Wong CX, et al. Obesity and the risk of incident, post-operative, and postablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: Clinical Electrophysiology. 2015;1(3):139–152. PubMed

Alonso A, et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial. Am Heart J. 2015;170(4):770–777.e5. PubMed PMC

Pathak RK, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–2231. PubMed

Bitter T, et al. Sleep-disordered breathing and cardiac arrhythmias. Can J Cardiol. 2015;31(7):928–934. PubMed

Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol. 2000;119(2-3):189–197. PubMed

Kraiczi H, et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol (1985) 2000;89(2):493–498. PubMed

Ghias M, et al. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54(22):2075–2083. PubMed

Linz D, et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8(9):1436–1443. PubMed

Linz D, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172–178. PubMed

Linz D, et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013;62(4):767–774. PubMed

Iwasaki YK, et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm. 2012;9(9):1409–1416.e1. PubMed

Iwasaki YK, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64(19):2013–2023. PubMed

Dimitri H, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321–327. PubMed

Stevenson IH, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7(9):1263–1270. PubMed

Holmqvist F, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Am Heart J. 2015;169(5):647–654.e2. PubMed

Kwon Y, et al. Association of sleep characteristics with atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2015;70(9):873–879. PubMed PMC

Kanagala R, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–2594. PubMed

Fein AS, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305. PubMed

Matiello M, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010;12(8):1084–1089. PubMed

Naruse Y, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10(3):331–337. PubMed

Neilan TG, et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013;2(6):e000421. PubMed PMC

Li L, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16(9):1309–1314. PubMed

Kannel WB, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018–1022. PubMed

Krahn AD, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476–484. PubMed

Thomas MC, et al. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens. 2008;21(10):1111–1116. PubMed PMC

Tremblay-Gravel M, et al. Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and AFFIRM Analysis. J Cardiovasc Electrophysiol. 2015;26(5):509–514. PubMed

Grundvold I, et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension. 2012;59(2):198–204. PubMed

Conen D, et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119(16):2146–2152. PubMed PMC

Kistler PM, et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J. 2006;27(24):3045–3056. PubMed

Berruezo A, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J. 2007;28(7):836–841. PubMed

Arya A, et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace. 2010;12(2):173–180. PubMed

Santoro F, et al. Impact of Uncontrolled Hypertension on Atrial Fibrillation Ablation Outcome. JACC: Clinical Electrophysiology. 2015;1(3):164–173. PubMed

Pokushalov E, et al. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11(7):1131–1138. PubMed

Healey JS, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45(11):1832–1839. PubMed

Al Chekakie MO, et al. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol. 2007;18(9):942–946. PubMed

Tayebjee MH, et al. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation. Europace. 2010;12(11):1537–1542. PubMed

Kato T, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006;17(8):890–894. PubMed

Huxley RR, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56–62. PubMed PMC

Huxley RR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart. 2012;98(2):133–138. PubMed PMC

Lin KJ, et al. Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis. J Interv Card Electrophysiol. 2014;39(3):211–223. PubMed PMC

Ettinger PO, et al. Arrhythmias and the “Holiday Heart”: alcohol-associated cardiac rhythm disorders. Am Heart J. 1978;95(5):555–562. PubMed

Patel N, et al. Does alcohol use increase the risk of atrial fibrillation recurrence after radiofrequency ablation? J Am Coll Cardiol. 2013;61(10_S)

Mohanty S, et al. Impact of alcohol intake on thromboembolic events following catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2014;63(12_S)

Qiao Y, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4(11) PubMed PMC

Wilber DJ. Fibroblasts, focal triggers, and persistent atrial fibrillation: is there a connection? Circ Arrhythm Electrophysiol. 2012;5(2):249–251. PubMed

Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ Arrhythm Electrophysiol. 2012;5(2):442–452. PubMed

Qureshi WT, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) project. Circulation. 2015;131(21):1827–1834. PubMed

Malmo V, et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133(5):466–473. PubMed

Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11(9):1156–1159. PubMed

Aizer A, et al. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009;103(11):1572–1577. PubMed PMC

Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11(1):11–17. PubMed PMC

Hoogsteen J, et al. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace. 2004;6(3):222–228. PubMed

Pelliccia A, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46(4):690–696. PubMed

Swanson DR. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses. 2006;66(6):1085–1092. PubMed

Heidbuchel H, et al. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol. 2006;107(1):67–72. PubMed

Andersen K, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34(47):3624–3631. PubMed

Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105(23):2753–2759. PubMed

Pelliccia A, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130(1):23–31. PubMed

Eijsvogels TM, Fernandez AB, Thompson PD. Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise? Physiol Rev. 2016;96(1):99–125. PubMed PMC

Allison MA, et al. Sedentary behavior and adiposity-associated inflammation: the Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. 2012;42(1):8–13. PubMed PMC

Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563–1569. PubMed

Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26(20):2083–2092. PubMed

Chung MK, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104(24):2886–2891. PubMed

Korantzopoulos P, et al. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit. 2003;9(9):RA225–RA229. PubMed

Psychari SN, et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95(6):764–767. PubMed

Mohlenkamp S, et al. Running: the risk of coronary events: Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29(15):1903–1910. PubMed

Marrouche NF, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506. PubMed

Benito B, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation. 2011;123(1):13–22. PubMed

Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med. 2007;41(7):447–452. PubMed PMC

Gay-Jordi G, et al. Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS One. 2013;8(2):e55427. PubMed PMC

Sorokin AV, et al. Atrial fibrillation in endurance-trained athletes. Br J Sports Med. 2011;45(3):185–188. PubMed

Calvo N, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12(1):30–36. PubMed PMC

Koopman P, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13(10):1386–1393. PubMed

Furlanello F, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008;19(5):457–462. PubMed

Pathak RK, et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol. 2015;66(9):985–996. PubMed

Fjeldsoe B, et al. Systematic review of maintenance of behavior change following physical activity and dietary interventions. Health Psychol. 2011;30(1):99–109. PubMed

European Heart Rhythm, A, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace. 2010;12(10):1360–1420. PubMed

Camm AJ, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747. PubMed

Wazni OM, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634–2640. PubMed

Cosedis Nielsen J, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–1595. PubMed

Morillo CA, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692–700. PubMed

Hakalahti A, et al. Radiofrequency ablation vs antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace. 2015;17(3):370–378. PubMed

Hocini M, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108(10):1172–1175. PubMed

Chen YW, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37(4):403–411. PubMed

Inada K, et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2014;16(2):208–213. PubMed

Tondo C, et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol. 2006;29(9):962–970. PubMed

Bunch TJ, et al. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19(10):1009–1014. PubMed

Lutomsky BA, et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace. 2008;10(5):593–599. PubMed

Choi AD, et al. Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. Congest Heart Fail. 2010;16(1):10–14. PubMed

De Potter T, et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace. 2010;12(1):24–29. PubMed PMC

Cha YM, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4(5):724–732. PubMed

Jones DG, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in HF. J Am Coll Cardiol. 2013;61(18):1894–1903. PubMed

Machino-Ohtsuka T, et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62(20):1857–1865. PubMed

Al Halabi S, et al. Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. JACC Clin Electrophysiol. 2015;1(3):200–209. PubMed PMC

Bunch TJ, et al. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2015;26(4):363–370. PubMed

Lobo TJ, et al. Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes. Arq Bras Cardiol. 2015;104(1):45–52. PubMed PMC

Ling LH, et al. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013;10(9):1334–1339. PubMed

Spragg DD, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008;19(6):627–631. PubMed

Kusumoto F, et al. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol. 2009;25(1):31–35. PubMed

Bunch TJ, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol. 2010;33(2):146–152. PubMed

Santangeli P, et al. Ablation for atrial fibrillation: termination of atrial fibrillation is not the end point. Card Electrophysiol Clin. 2012;4(3):343–352. PubMed

Santangeli P, et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis. Circ Arrhythm Electrophysiol. 2012;5(2):302–311. PubMed

Santangeli P, et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23(7):687–693. PubMed

Nademanee K, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12(1):44–51. PubMed

Bunch TJ, et al. The impact of age on 5-year outcomes after atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2016;27(2):141–146. PubMed

Metzner I, et al. Ablation of atrial fibrillation in patients >/=75 years: long-term clinical outcome and safety. Europace. 2016;18(4):543–549. PubMed

Leong-Sit P, et al. Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ Arrhythm Electrophysiol. 2010;3(5):452–457. PubMed

Oral H, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006;114(8):759–765. PubMed

Hussein AA, et al. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(3):271–278. PubMed

Hunter RJ, et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart. 2012;98(1):48–53. PubMed

Winkle RA, et al. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Interv Card Electrophysiol. 2013;38(3):147–153. PubMed PMC

Karasoy D, et al. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: longterm follow-up in nationwide cohort of Denmark. Eur Heart J. 2015;36(5):307–314a. PubMed

Schlingloff F, et al. Oral anticoagulation after successful atrial fibrillation ablation operations: is it necessary? Ann Thorac Surg. 2016;101(4):1471–1476. PubMed

Nuhrich JM, et al. Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry. Clin Res Cardiol. 2015;104(6):463–470. PubMed

Oral H, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2004;15(8):920–924. PubMed

Tondo C, et al. Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):154–160. PubMed

Kirchhof P, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. PubMed

Forleo GB, et al. Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation: the IRON-AF (Italian registry on NavX atrial fibrillation ablation procedures) study. Int J Cardiol. 2013;168(4):3968–3970. PubMed

Mohanty S, et al. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014;25(10):1057–1064. PubMed

Wu L, et al. Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis. J Cardiovasc Electrophysiol. 2016;27(5):531–535. PubMed

Cox JL, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101(3):406–426. PubMed

Sundt TM, 3rd, Camillo CJ, Cox JL. The maze procedure for cure of atrial fibrillation. Cardiol Clin. 1997;15(4):739–748. PubMed

Melo J, et al. Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. Eur J Cardiothorac Surg. 1999;15(6):851–854. discussion 855. PubMed

Sueda T, et al. Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery. Ann Thorac Surg. 2001;71(4):1189–1193. PubMed

Swartz JF, P G, Silvers J, Pattern L, Cervantez D. A catheter-based curative approach to atrial fibrillation in humans. [abstract] Circulation. 1994;90(Suppl I):I–335.

Haissaguerre M, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7(12):1132–1144. PubMed

Gaita F, et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation. 1998;97(21):2136–2145. PubMed

Jais P, et al. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1998;21(11 Pt 2):2533–2538. PubMed

Calkins H, et al. A new system for catheter ablation of atrial fibrillation. Am J Cardiol. 1999;83(5B):227D–236D. PubMed

Natale A, et al. Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy: long-term results. Pacing Clin Electrophysiol. 2000;23(2):224–233. PubMed

Kocheril AG, et al. Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation. J Interv Card Electrophysiol. 2005;12(3):189–197. PubMed

Haissaguerre M, et al. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. J Cardiovasc Electrophysiol. 1994;5(9):743–751. PubMed

Jais P, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95(3):572–576. PubMed

Pappone C, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation. 1999;100(11):1203–1208. PubMed

Haissaguerre M, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101(12):1409–1417. PubMed

Robbins IM, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation. 1998;98(17):1769–1775. PubMed

Marrouche NF, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation. 2003;107(21):2710–2716. PubMed

Oral H, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation. 2002;106(10):1256–1262. PubMed

Pappone C, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001;104(21):2539–2544. PubMed

Ouyang F, et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation. 2004;110(15):2090–2096. PubMed

Takahashi A, et al. Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation. Circulation. 2002;105(25):2998–3003. PubMed

Callans DJ, et al. Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(9):1050–1055. PubMed

Oral H, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003;108(19):2355–2360. PubMed

Karch MR, et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005;111(22):2875–2880. PubMed

Arentz T, et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation. 2007;115(24):3057–3063. PubMed

Yamada T, et al. Electrophysiological pulmonary vein antrum isolation with a multielectrode basket catheter is feasible and effective for curing paroxysmal atrial fibrillation: efficacy of minimally extensive pulmonary vein isolation. Heart Rhythm. 2006;3(4):377–384. PubMed

Gerstenfeld EP, et al. Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol. 2002;13(10):971–979. PubMed

Nanthakumar K, et al. Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy? Circulation. 2004;109(10):1226–1229. PubMed

Ouyang F, et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation. 2005;111(2):127–135. PubMed

Cheema A, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(4):387–391. PubMed

Pratola C, et al. Radiofrequency ablation of atrial fibrillation: is the persistence of all intraprocedural targets necessary for long-term maintenance of sinus rhythm? Circulation. 2008;117(2):136–143. PubMed

Rajappan K, et al. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomical sites. Pacing Clin Electrophysiol. 2008;31(12):1598–1605. PubMed

Bansch D, et al. Circumferential pulmonary vein isolation: wait or stop early after initial successful pulmonary vein isolation? Europace. 2013;15(2):183–188. PubMed

Nakamura K, et al. Optimal observation time after completion of circumferential pulmonary vein isolation for atrial fibrillation to prevent chronic pulmonary vein reconnections. Int J Cardiol. 2013;168(6):5300–5310. PubMed

Neuzil P, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6(2):327–333. PubMed

Jiang RH, et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. Heart Rhythm. 2014;11(6):969–976. PubMed

Kim TH, et al. Pulmonary vein reconnection predicts good clinical outcome after second catheter ablation for atrial fibrillation. Europace. 2016 Epub ahead of print. PubMed

Kuck KH, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial. Circ Arrhythm Electrophysiol. 2016;9(1):e003337. PubMed

Wang XH, et al. Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace. 2007;9(7):481–486. PubMed

Sauer WH, et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slowpathway modification. Circulation. 2006;114(3):191–195. PubMed

Ninomiya Y, et al. Usefulness of the adenosine triphosphate with a sufficient observation period for detecting reconduction after pulmonary vein isolation. Pacing Clin Electrophysiol. 2009;32(10):1307–1312. PubMed

Yamane T, et al. Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure. Circ Arrhythm Electrophysiol. 2011;4(5):601–608. PubMed

Kobori A, et al. Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. Eur Heart J. 2015;36(46):3276–3287. PubMed

Packer DL, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–1723. PubMed

Arentz T, et al. “Dormant” pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2004;15(9):1041–1047. PubMed

Tritto M, et al. Adenosine restores atrio-venous conduction after apparently successful ostial isolation of the pulmonary veins. Eur Heart J. 2004;25(23):2155–2163. PubMed

Datino T, et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation. 2010;121(8):963–972. PubMed

Dallaglio PD, et al. The role of adenosine in pulmonary vein isolation: a critical review. Cardiol Res Pract. 2016;2016:8632509. PubMed PMC

Kapa S, et al. Dose-dependent pulmonary vein reconnection in response to adenosine: relevance of atrioventricular block during infusion. J Interv Card Electrophysiol. 2016;47(1):117–123. PubMed

Andrade JG, et al. Pulmonary vein isolation using “contact force” ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation– a prospective study. Heart Rhythm. 2014;11(11):1919–1924. PubMed

Miyazaki S, et al. Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(3):256–260. PubMed

Zhang J, et al. Origin and ablation of the adenosine triphosphate induced atrial fibrillation after circumferential pulmonary vein isolation: effects on procedural success rate. J Cardiovasc Electrophysiol. 2014;25(4):364–370. PubMed

Datino T, et al. Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation. Heart Rhythm. 2011;8(9):1426–1433. PubMed

Steven D, et al. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm. 2010;7(3):323–330. PubMed

Andrade JG, et al. Pulmonary vein isolation using a pace-capture-guided versus an adenosine-guided approach: effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study. Circ Arrhythm Electrophysiol. 2013;6(6):1103–1108. PubMed

Steven D, et al. Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial. J Am Coll Cardiol. 2013;62(1):44–50. PubMed

Schaeffer B, et al. Loss of pace capture on the ablation line during pulmonary vein isolation versus “dormant conduction”: is adenosine expendable? J Cardiovasc Electrophysiol. 2015;26(10):1075–1080. PubMed

Weerasooriya R, et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2003;26(1 Pt 2):292–294. PubMed

Vijayaraman P, et al. Assessment of exit block following pulmonary vein isolation: far-field capture masquerading as entrance without exit block. Heart Rhythm. 2012;9(10):1653–1659. PubMed

Ip JE, et al. Method for differentiating left superior pulmonary vein exit conduction from pseudo-exit conduction. Pacing Clin Electrophysiol. 2013;36(3):299–308. PubMed

Spector P. Principles of cardiac electric propagation and their implications for reentrant arrhythmias. Circ Arrhythm Electrophysiol. 2013;6(3):655–661. PubMed

Chen S, et al. Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35(5):524–531. PubMed

Kim JY, et al. Achievement of successful pulmonary vein isolation: methods of adenosine testing and incremental benefit of exit block. J Interv Card Electrophysiol. 2016;46(3):315–324. PubMed

Andrade JG, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–1451. PubMed

Furnkranz A, et al. Characterization of conduction recovery after pulmonary vein isolation using the “single big cryoballoon” technique. Heart Rhythm. 2010;7(2):184–190. PubMed

Furnkranz A, et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol. 2013;24(5):492–497. PubMed

Ciconte G, et al. Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second-generation device. J Cardiovasc Electrophysiol. 2014;25(8):845–851. PubMed

Metzner A, et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014;7(2):288–292. PubMed

Bordignon S, et al. High rate of durable pulmonary vein isolation after secondgeneration cryoballoon ablation: analysis of repeat procedures. Europace. 2015;17(5):725–731. PubMed

Heeger CH, et al. Bonus-freeze: benefit or risk? Two-year outcome and procedural comparison of a “bonus-freeze” and “no bonus-freeze” protocol using the second-generation cryoballoon for pulmonary vein isolation. Clin Res Cardiol. 2016;105(9):774–782. PubMed PMC

Kuck KH, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–2245. PubMed

Kuck KH, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38):2858–2865. PubMed PMC

Miyazaki S, et al. Durability of cryothermal pulmonary vein isolation—Creating contiguous lesions is necessary for persistent isolation. Int J Cardiol. 2016;220:395–399. PubMed

Straube F, et al. First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace. 2016;18(3):368–375. PubMed

Straube F, et al. Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol. J Interv Card Electrophysiol. 2016;45(2):169–177. PubMed

Raatikainen MJ, et al. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial. Int J Cardiol. 2015;198:108–114. PubMed

Kumar N, et al. Adenosine testing after second-generation cryoballoon ablation (ATSCA) study improves clinical success rate for atrial fibrillation. Europace. 2015;17(6):871–876. PubMed

Schmidt B, et al. Feasibility of circumferential pulmonary vein isolation using a novel endoscopic ablation system. Circ Arrhythm Electrophysiol. 2010;3(5):481–488. PubMed

Dukkipati SR, et al. The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies. Heart Rhythm. 2012;9(6):919–925. PubMed

Dukkipati SR, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6(3):467–472. PubMed

Metzner A, et al. Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study. J Cardiovasc Electrophysiol. 2013;24(1):7–13. PubMed

Metzner A, et al. The influence of varying energy settings on efficacy and safety of endoscopic pulmonary vein isolation. Heart Rhythm. 2012;9(9):1380–1385. PubMed

Bordignon S, et al. Comparison of balloon catheter ablation technologies for pulmonary vein isolation: the laser versus cryo study. J Cardiovasc Electrophysiol. 2013;24(9):987–994. PubMed

Bordignon S, et al. Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study. Europace. 2013;15(5):685–689. PubMed

Dukkipati SR, et al. Pulmonary vein isolation using the visually guided laser balloon: a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol. 2015;66(12):1350–1360. PubMed

Patel NJ, et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 2016;13(6):1317–1325. PubMed

Ernst S, et al. Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease. J Cardiovasc Electrophysiol. 2003;14(4):366–370. PubMed

Pappone C, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation. 2004;110(19):3036–3042. PubMed

Sawhney N, et al. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(3):243–248. PubMed

Chae S, et al. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J Am Coll Cardiol. 2007;50(18):1781–1787. PubMed

Vogler J, et al. Pulmonary vein isolation versus defragmentation: the CHASEAF clinical trial. J Am Coll Cardiol. 2015;66(24):2743–2752. PubMed

Ouyang F, et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation. 2002;105(16):1934–1942. PubMed

Wazni O, et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation. 2003;108(20):2479–2483. PubMed

Matsuo S, et al. Peri-mitral atrial flutter in patients with atrial fibrillation ablation. Heart Rhythm. 2010;7(1):2–8. PubMed

Tzeis S, et al. The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol. 2010;21(6):665–670. PubMed

Haissaguerre M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16(11):1138–1147. PubMed

Scherr D, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18–24. PubMed

Nademanee K, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43(11):2044–2053. PubMed

O’Neill MD, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J. 2009;30(9):1105–1112. PubMed

Lo LW, et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm. 2009;6(3):311–318. PubMed

Zhang Z, et al. Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis. Pacing Clin Electrophysiol. 2016;39(6):623–630. PubMed

Kim TH, et al. Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized study. Europace. 2015;17(3):388–395. PubMed

Wynn GJ, et al. Biatrial linear ablation in sustained nonpermanent AF: results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm. 2016;13(2):399–406. PubMed

Kumagai K, et al. A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(10):1047–1052. PubMed

Yamaguchi Y, et al. Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J. 2010;74(6):1096–1103. PubMed

Kumagai K. Catheter ablation of atrial fibrillation. State of the Art Circ J. 2011;75(10):2305–2311. PubMed

Kim JS, et al. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation? A prospective randomized clinical trial. Int J Cardiol. 2015;181:277–283. PubMed

He X, et al. Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2016;46(3):267–274. PubMed

Tamborero D, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol. 2009;2(1):35–40. PubMed

Di Biase L, et al. Left atrial appendage isolation in patients with long-standing persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–1940. PubMed

Di Biase L, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637–1644. PubMed

Shah D, et al. Nonpulmonary vein foci: do they exist? Pacing Clin Electrophysiol. 2003;26(7 Pt 2):1631–1635. PubMed

Lin D, et al. Provocability of atrial fibrillation triggers during pulmonary vein isolation in patients with infrequent AF [abstract] Heart Rhythm. 2004;1(Suppl):S231.

Di Biase L, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121(23):2550–2556. PubMed

Di Biase L, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–118. PubMed

Santangeli P, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016;13(2):374–382. PubMed

Lin WS, et al. Catheter ablation of paroxysmal atrial fibrillation initiated by nonpulmonary vein ectopy. Circulation. 2003;107(25):3176–3183. PubMed

Lakkireddy D, et al. Effect of atrial fibrillation ablation on gastric motility: the atrial fibrillation gut study. Circ Arrhythm Electrophysiol. 2015;8(3):531–536. PubMed

Lee RJ, et al. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design. Am Heart J. 2015;170(6):1184–1194. PubMed

Zhao Y, et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13(1):141–149. PubMed

Dixit S, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5(2):287–294. PubMed

Dagres N, et al. Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace. 2015;17(10):1596–1600. PubMed

Hocini M, et al. Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm. 2011;8(12):1853–1861. PubMed PMC

Panikker S, et al. Left atrial appendage electrical isolation and concomitant device occlusion: A safety and feasibility study with histologic characterization. Heart Rhythm. 2015;12(1):202–210. PubMed

Panikker S, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7) PubMed

Rillig A, et al. Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2016;9(5):e003461. PubMed

Nademanee K, et al. Clinical outcomes of catheter substrate ablation for highrisk patients with atrial fibrillation. J Am Coll Cardiol. 2008;51(8):843–849. PubMed

Haissaguerre M, et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation. 2006;113(5):616–625. PubMed

Haissaguerre M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol. 2005;16(11):1125–1137. PubMed

Takahashi Y, et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol. 2008;51(10):1003–1010. PubMed

Singh SM, et al. Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(6):608–616. PubMed

Narayan SM, et al. Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm. 2011;8(2):244–253. PubMed PMC

Verma A, et al. Selective CFAE targeting for atrial fibrillation study (SELECT AF): clinical rationale, design, and implementation. J Cardiovasc Electrophysiol. 2011;22(5):541–547. PubMed

Quintanilla JG, et al. Mechanistic approaches to detect, target, and ablate the drivers of atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(1):e002481. PubMed PMC

Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation: how to modify the substrate? J Am Coll Cardiol. 2015;65(2):196–206. PubMed

Rolf S, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(5):825–833. PubMed

Bai R, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13(1):132–140. PubMed

Cutler MJ, et al. Impact of voltage mapping to guide whether to perform ablation of the posterior wall in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):13–21. PubMed

Yang G, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2016;9(2):e003382. PubMed

Verma A, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45(2):285–292. PubMed

Kapa S, et al. Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(10):1044–1052. PubMed

Oakes RS, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758–1767. PubMed PMC

McGann C, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol. 2014;7(1):23–30. PubMed PMC

Lin YJ, et al. Electrophysiological characteristics and catheter ablation in patients with paroxysmal right atrial fibrillation. Circulation. 2005;112(12):1692–1700. PubMed

Narayan SM, et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012;60(7):628–636. PubMed PMC

Rappel WJ, Narayan SM. Theoretical considerations for mapping activation in human cardiac fibrillation. Chaos. 2013;23(2):023113. PubMed PMC

Gianni C, et al. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016;13(4):830–835. PubMed

Narayan SM, Zaman JA. Mechanistically based mapping of human cardiac fibrillation. J Physiol. 2016;594(9):2399–2415. PubMed PMC

Sommer P, et al. Successful repeat catheter ablation of recurrent long-standing persistent atrial fibrillation with rotor elimination as the procedural endpoint: a case series. J Cardiovasc Electrophysiol. 2016;27(3):274–280. PubMed

Buch E, et al. Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experience. Heart Rhythm. 2016;13(3):636–641. PubMed PMC

Benharash P, et al. Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillation. Circ Arrhythm Electrophysiol. 2015;8(3):554–561. PubMed PMC

Ramanathan C, et al. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med. 2004;10(4):422–428. PubMed PMC

Lim HS, et al. Noninvasive mapping to guide atrial fibrillation ablation. Card Electrophysiol Clin. 2015;7(1):89–98. PubMed

Yamashita S, et al. Body surface mapping to guide atrial fibrillation ablation. Arrhythm Electrophysiol Rev. 2015;4(3):172–176. PubMed PMC

Guillem MS, et al. Noninvasive mapping of human atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(5):507–513. PubMed

Guillem MS, et al. Noninvasive localization of maximal frequency sites of atrial fibrillation by body surface potential mapping. Circ Arrhythm Electrophysiol. 2013;6(2):294–301. PubMed PMC

Rodrigo M, et al. Body surface localization of left and right atrial high-frequency rotors in atrial fibrillation patients: a clinical-computational study. Heart Rhythm. 2014;11(9):1584–1591. PubMed PMC

Pauza DH, et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259(4):353–382. PubMed

Scherlag BJ, et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13(Suppl 1):37–42. PubMed

Patterson E, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47(6):1196–1206. PubMed

Lemola K, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation. 2008;117(4):470–477. PubMed

Nishida K, et al. The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation. Cardiovasc Res. 2011;89(4):825–833. PubMed

Nishida K, et al. Atrial fibrillation ablation: translating basic mechanistic insights to the patient. J Am Coll Cardiol. 2014;64(8):823–831. PubMed

Stavrakis S, et al. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015;1(1-2):1–13. PubMed PMC

Pokushalov E, et al. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2010;33(10):1231–1238. PubMed

Pokushalov E, et al. Ganglionated plexi ablation for long-standing persistent atrial fibrillation. Europace. 2010;12(3):342–346. PubMed

Pokushalov E, et al. Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol. 2013;24(12):1338–1343. PubMed

Pokushalov E, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10(9):1280–1286. PubMed

Morillo CA, et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588–1595. PubMed

Harada A, et al. Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg. 1996;61(1):104–111. discussion 111-2. PubMed

Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature. 1998;392(6671):75–78. PubMed

Berenfeld O, et al. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused sheep heart. J Cardiovasc Electrophysiol. 2000;11(8):869–879. PubMed

Mansour M, et al. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation. 2001;103(21):2631–2636. PubMed

Lazar S, et al. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation. 2004;110(20):3181–3186. PubMed

Atienza F, et al. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm. 2009;6(1):33–40. PubMed PMC

Atienza F, et al. Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial. J Am Coll Cardiol. 2014;64(23):2455–2467. PubMed

Zhao Q, et al. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol. 2012;35(2):119–125. PubMed

Wang X, et al. Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing. Europace. 2015;17(4):647–654. PubMed

Zhou Q, et al. Renal sympathetic denervation suppresses atrial fibrillation induced by acute atrial ischemia/infarction through inhibition of cardiac sympathetic activity. Int J Cardiol. 2016;203:187–195. PubMed

Vollmann D, et al. Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation. Clin Res Cardiol. 2013;102(4):315–318. PubMed PMC

Schlaich MP, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20(5):933–939. PubMed

Bakris GL, et al. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015;65(13):1314–1321. PubMed

Boersma LV, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23–30. PubMed

Wang S, Liu L, Zou C. Comparative study of video-assisted thoracoscopic surgery ablation and radiofrequency catheter ablation on treating paroxysmal atrial fibrillation: a randomized, controlled short-term trial. Chin Med J (Engl) 2014;127(14):2567–2570. PubMed

Phan K, et al. Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation. Eur J Cardiothorac Surg. 2016;49(4):1044–1051. PubMed

Krul SP, et al. Epicardial and endocardial electrophysiological guided thoracoscopic surgery for atrial fibrillation: a multidisciplinary approach of atrial fibrillation ablation in challenging patients. Int J Cardiol. 2014;173(2):229–235. PubMed

Probst J, et al. Thoracoscopic epicardial left atrial ablation in symptomatic patients with atrial fibrillation. Europace. 2016;18(10):1538–1544. PubMed

Mahapatra S, et al. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–1898. PubMed PMC

Gersak B, et al. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(10):1059–1066. PubMed

Pison L, et al. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61. PubMed

Zembala M, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70(8):819–828. PubMed

Bisleri G, et al. Hybrid approach for the treatment of long-standing persistent atrial fibrillation: electrophysiological findings and clinical results. Eur J Cardiothorac Surg. 2013;44(5):919–923. PubMed

Gehi AK, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10(1):22–28. PubMed

La Meir M, et al. Minimally invasive surgical treatment of lone atrial fibrillation: early results of hybrid versus standard minimally invasive approach employing radiofrequency sources. Int J Cardiol. 2013;167(4):1469–1475. PubMed

Gersak B, et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients. J Thorac Cardiovasc Surg. 2014;147(4):1411–1416. PubMed

Kurfirst V, et al. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–456. PubMed PMC

Pison L, et al. Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):38–44. PubMed PMC

Bulava A, et al. Sequential hybrid procedure for persistent atrial fibrillation. J Am Heart Assoc. 2015;4(3):e001754. PubMed PMC

Raitt MH, et al. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(5):507–512. PubMed

Chalfoun N, et al. Reverse electrical remodeling of the atria post cardioversion in patients who remain in sinus rhythm assessed by signal averaging of the P-wave. Pacing Clin Electrophysiol. 2007;30(4):502–509. PubMed

Igarashi M, et al. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation. Am J Cardiol. 2010;106(1):62–68. PubMed

Rivard L, et al. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012;9(7):1025–1030. PubMed

Mohanty S, et al. Effect of periprocedural amiodarone on procedure outcome in patients with long-standing persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE) Heart Rhythm. 2015;12(3):477–483. PubMed

Gerstenfeld EP, et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation. 2004;110(11):1351–1357. PubMed

Chugh A, et al. Catheter ablation of atypical atrial flutter and atrial tachycardia within the coronary sinus after left atrial ablation for atrial fibrillation. J Am Coll Cardiol. 2005;46(1):83–91. PubMed

Chugh A, et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm. 2005;2(5):464–471. PubMed

Deisenhofer I, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace. 2006;8(8):573–582. PubMed

Mesas CE, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol. 2004;44(5):1071–1079. PubMed

Anter E, et al. Evaluation of a novel high-resolution mapping technology for ablation of recurrent scar-related atrial tachycardias. Heart Rhythm. 2016;13(10):2048–2055. PubMed

Shah D, et al. Narrow, slow-conducting isthmus dependent left atrial reentry developing after ablation for atrial fibrillation: ECG characterization and elimination by focal RF ablation. J Cardiovasc Electrophysiol. 2006;17(5):508–515. PubMed

Chugh A, et al. Characteristics of cavotricuspid isthmus-dependent atrial flutter after left atrial ablation of atrial fibrillation. Circulation. 2006;113(5):609–615. PubMed

Gerstenfeld EP, et al. Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation. Heart Rhythm. 2007;4(9):1136–1143. PubMed

Steven D, et al. Mapping of atrial tachycardias after catheter ablation for atrial fibrillation: use of bi-atrial activation patterns to facilitate recognition of origin. Heart Rhythm. 2010;7(5):664–672. PubMed

Anter E, et al. Pulmonary vein isolation using the Rhythmia mapping system: Verification of intracardiac signals using the Orion mini-basket catheter. Heart Rhythm. 2015;12(9):1927–1934. PubMed

Di Biase L, et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Heart Rhythm. 2011;8(3):368–372. PubMed

Hutchinson MD, et al. Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm. 2013;10(3):347–353. PubMed

Nair KK, et al. The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience. J Interv Card Electrophysiol. 2014;39(2):139–144. PubMed

Di Biase L, et al. Relationship between catheter forces, lesion characteristics, “popping,” and char formation: experience with robotic navigation system. J Cardiovasc Electrophysiol. 2009;20(4):436–440. PubMed

Di Biase L, et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythm Electrophysiol. 2009;2(2):108–112. PubMed

Martinek M, et al. Esophageal damage during radiofrequency ablation of atrial fibrillation: impact of energy settings, lesion sets, and esophageal visualization. J Cardiovasc Electrophysiol. 2009;20(7):726–733. PubMed

Martinek M, et al. Acute development of gastroesophageal reflux after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2009;6(10):1457–1462. PubMed

Sadek MM, et al. Recurrent atrial arrhythmias in the setting of chronic pulmonary vein isolation. Heart Rhythm. 2016;13(11):2174–2180. PubMed

Elayi CS, et al. Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm. 2010;7(9):1216–1223. PubMed

Lim HS, et al. Is ablation to termination the best strategy for ablation of persistent atrial fibrillation? Persistent atrial fibrillation is best ablated by a strategy that terminates the arrhythmia: procedural termination is associated with improved long-term outcomes. Circ Arrhythm Electrophysiol. 2015;8(4):963–971. PubMed

Kochhauser S, et al. Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: a substudy of the STAR AF II trial. Heart Rhythm. 2017;14(4):476–483. PubMed

Scott PA, Silberbauer J, Murgatroyd FD. The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis. Europace. 2016;18(3):359–367. PubMed

Zaman JA, Peters NS, Narayan SM. Rotor mapping and ablation to treat atrial fibrillation. Curr Opin Cardiol. 2015;30(1):24–32. PubMed PMC

Bai R, et al. Ablation of perimitral flutter following catheter ablation of atrial fibrillation: impact on outcomes from a randomized study (PROPOSE) J Cardiovasc Electrophysiol. 2012;23(2):137–144. PubMed

Bai R, et al. Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safety. J Cardiovasc Electrophysiol. 2012;23(8):820–826. PubMed

Kobza R, et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm. 2004;1(6):676–683. PubMed

Ouyang F, et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation. 2005;112(20):3038–3048. PubMed

Boersma LV, et al. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm. 2008;5(12):1635–1642. PubMed

Jais P, et al. Successful irrigated-tip catheter ablation of atrial flutter resistant to conventional radiofrequency ablation. Circulation. 1998;98(9):835–838. PubMed

Haines DE. The biophysics and pathophysiology of lesion formation during radiofrequency catheter ablation. In: Zipes D, J J, editors. Cardiac Electrophysiology: From Cell to Bedside. 4. New York: WB Saunders; 2006. pp. 1018–1027.

Haines DE, et al. The biophysics of passive convective cooling during catheter ablation with gold versus platinum electrodes and multielectrode phased radiofrequency energy delivery. J Cardiovasc Electrophysiol. 2015 Epub ahead of print. PubMed

Nakagawa H, et al. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation. 1995;91(8):2264–2273. PubMed

Reddy VY, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) study. Circulation. 2015;132(10):907–915. PubMed

Finta B, Haines DE. Catheter ablation therapy for atrial fibrillation. Cardiol Clin. 2004;22(1):127–145, ix. PubMed

Thomas SP, et al. A comparison of open irrigated and non-irrigated tip catheter ablation for pulmonary vein isolation. Europace. 2004;6(4):330–335. PubMed

Bruce GK, et al. Discrepancies between catheter tip and tissue temperature in cooled-tip ablation: relevance to guiding left atrial ablation. Circulation. 2005;112(7):954–960. PubMed

Oh S, et al. Avoiding microbubbles formation during radiofrequency left atrial ablation versus continuous microbubbles formation and standard radiofrequency ablation protocols: comparison of energy profiles and chronic lesion characteristics. J Cardiovasc Electrophysiol. 2006;17(1):72–77. PubMed

Tanno K, et al. Histopathology of canine hearts subjected to catheter ablation using radiofrequency energy. Jpn Circ J. 1994;58(2):123–135. PubMed

Nath S, et al. Cellular electrophysiological effects of hyperthermia on isolated guinea pig papillary muscle. Implications for catheter ablation. Circulation. 1993;88(4 Pt 1):1826–1831. PubMed

Everett THt, et al. Role of calcium in acute hyperthermic myocardial injury. J Cardiovasc Electrophysiol. 2001;12(5):563–569. PubMed

Saad EB, et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation. 2003;108(25):3102–3107. PubMed

Bunch TJ, et al. Analysis of catheter-tip (8-mm) and actual tissue temperatures achieved during radiofrequency ablation at the orifice of the pulmonary vein. Circulation. 2004;110(19):2988–2995. PubMed

Haines DE. Determinants of lesion size during radiofrequency catheter ablation: the role of electrode-tissue contact pressure and duration of energy delivery. Journal of Cardiovascular Electrophysiology. 1991;2(6):509–515.

Strickberger SA, et al. Relation between impedance and endocardial contact during radiofrequency catheter ablation. Am Heart J. 1994;128(2):226–229. PubMed

Avitall B, et al. The effects of electrode-tissue contact on radiofrequency lesion generation. Pacing Clin Electrophysiol. 1997;20(12 Pt 1):2899–2910. PubMed

Yokoyama K, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1(5):354–362. PubMed

Kuck KH, et al. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm. 2012;9(1):18–23. PubMed

Ikeda A, et al. Relationship between catheter contact force and radiofrequency lesion size and incidence of steam pop in the beating canine heart: electrogram amplitude, impedance, and electrode temperature are poor predictors of electrode-tissue contact force and lesion size. Circ Arrhythm Electrophysiol. 2014;7(6):1174–1180. PubMed

Nakagawa H, et al. Locations of high contact force during left atrial mapping in atrial fibrillation patients: electrogram amplitude and impedance are poor predictors of electrode-tissue contact force for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(4):746–753. PubMed

Nakagawa H, et al. Prospective study to test the ability to create RF lesions at predicted depth and diameter using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) in the beating heart [abstract] Heart Rhythm. 2014;11(Suppl):S548.

Natale A, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J AmColl Cardiol. 2014;64(7):647–656. PubMed

Kumar S, et al. Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm. 2013;10(7):962–969. PubMed

Kumar S, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5(6):1124–1129. PubMed

Reddy VY, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9(11):1789–1795. PubMed

Haldar S, et al. Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study. Int J Cardiol. 2013;168(2):1160–1166. PubMed

Perna F, et al. Assessment of catheter tip contact force resulting in cardiac perforation in swine atria using force sensing technology. Circ Arrhythm Electrophysiol. 2011;4(2):218–224. PubMed

Kimura M, et al. Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study. Heart Rhythm. 2014;11(6):984–991. PubMed

Sohns C, et al. Quantitative magnetic resonance imaging analysis of the relationship between contact force and left atrial scar formation after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):138–145. PubMed

Martinek M, et al. Clinical impact of an open-irrigated radiofrequency catheter with direct force measurement on atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35(11):1312–1318. PubMed

Marijon E, et al. Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: procedural and 1-year results. J Cardiovasc Electrophysiol. 2014;25(2):130–137. PubMed

Sigmund E, et al. Optimizing radiofrequency ablation of paroxysmal and persistent atrial fibrillation by direct catheter force measurement-a case-matched comparison in 198 patients. Pacing Clin Electrophysiol. 2015;38(2):201–208. PubMed

Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–340. PubMed

Ullah W, et al. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data. Heart Rhythm. 2016;13(9):1761–1767. PubMed

Wakili R, et al. Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation. Clin Res Cardiol. 2014;103(2):97–106. PubMed

Van Belle Y, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J. 2007;28(18):2231–2237. PubMed

Neumann T, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol. 2008;52(4):273–278. PubMed

Reddy VY, et al. Durability of pulmonary vein isolation with cryoballoon ablation: results fromthe Sustained PV Isolation with Arctic Front Advance (SUPIR) study. J Cardiovasc Electrophysiol. 2015;26(5):493–500. PubMed

Coulombe N, Paulin J, Su W. Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2013;24(8):919–925. PubMed

Straube F, et al. Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol. 2014;7(2):293–299. PubMed

Straube F, et al. Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Europace. 2014;16(10):1434–1442. PubMed

Schmidt M, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2014;25(1):1–7. PubMed

Linhart M, et al. Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol. 2009;20(12):1343–1348. PubMed

Aryana A, et al. Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: a multicenter experience. J Cardiovasc Electrophysiol. 2015;26(8):832–839. PubMed

Hunter RJ, et al. Point-by-point radiofrequency ablation versus the cryoballoon or a novel combined approach: a randomized trial comparing 3 methods of pulmonary vein isolation for paroxysmal atrial fibrillation (The Cryo Versus RF Trial) J Cardiovasc Electrophysiol. 2015;26(12):1307–1314. PubMed

Furnkranz A, et al. Rationale and Design of FIRE AND ICE: A multicenter randomized trial comparing efficacy and safety of pulmonary vein isolation using a cryoballoon versus radiofrequency ablation with 3D-reconstruction. J Cardiovasc Electrophysiol. 2014;25(12):1314–1320. PubMed

Namdar M, et al. Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace. 2012;14(2):197–203. PubMed

Dukkipati SR, et al. Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2010;3(3):266–273. PubMed

Metzner A, et al. Esophageal temperature change and esophageal thermal lesions after pulmonary vein isolation using the novel endoscopic ablation system. Heart Rhythm. 2011;8(6):815–820. PubMed

Metzner A, et al. One-year clinical outcome after pulmonary vein isolation using the novel endoscopic ablation system in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2011;8(7):988–993. PubMed

Koruth JS, et al. Pre-clinical investigation of a low-intensity collimated ultrasound system for pulmonary vein isolation in a porcine model. JACC: Clinical Electrophysiology. 2015;1(4):306–314. PubMed

Meininger GR, et al. Initial experience with a novel focused ultrasound ablation system for ring ablation outside the pulmonary vein. J Interv Card Electrophysiol. 2003;8(2):141–148. PubMed

Metzner A, et al. Long-term clinical outcome following pulmonary vein isolation with high-intensity focused ultrasound balloon catheters in patients with paroxysmal atrial fibrillation. Europace. 2010;12(2):188–193. PubMed

Neven K, et al. Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound. Circ Arrhythm Electrophysiol. 2010;3(3):260–265. PubMed

Sohara H, et al. Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2(3):225–232. PubMed

Evonich RF, Nori DM, Haines DE. Efficacy of pulmonary vein isolation with a novel hot balloon ablation catheter. J Interv Card Electrophysiol. 2012;34(1):29–36. PubMed

Yamaguchi Y, et al. Long-term results of radiofrequency hot balloon ablation in patients with paroxysmal atrial fibrillation: safety and rhythm outcomes. J Cardiovasc Electrophysiol. 2015;26(12):1298–1306. PubMed

Sohara H, et al. HotBalloon ablation of the pulmonary veins for paroxysmal AF: a multicenter randomized trial in Japan. J Am Coll Cardiol. 2016;68(25):2747–2757. PubMed

Mansour M, et al. Initial experience with the Mesh catheter for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2008;5(11):1510–1516. PubMed

Steinwender C, et al. Acute results of pulmonary vein isolation in patients with paroxysmal atrial fibrillation using a single mesh catheter. J Cardiovasc Electrophysiol. 2009;20(2):147–152. PubMed

Hofmann R, et al. Pulmonary vein isolation with Mesh Ablator versus cryoballoon catheters: 6-month outcomes. J Interv Card Electrophysiol. 2010;29(3):179–185. PubMed

Steinwender C, et al. One-year follow-up after pulmonary vein isolation using a single mesh catheter in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2010;7(3):333–339. PubMed

Koch L, et al. Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study. Europace. 2012;14(10):1441–1449. PubMed

Shin DI, et al. Initial results of using a novel irrigated multielectrode mapping and ablation catheter for pulmonary vein isolation. Heart Rhythm. 2014;11(3):375–383. PubMed

Zellerhoff S, et al. Pulmonary vein isolation using a circular, open irrigated mapping and ablation catheter (nMARQ): a report on feasibility and efficacy. Europace. 2014;16(9):1296–1303. PubMed

Rodriguez-Entem F, et al. Initial experience and treatment of atrial fibrillation using a novel irrigated multielectrode catheter: Results from a prospective two-center study. J Arrhythm. 2016;32(2):95–101. PubMed PMC

Stabile G, et al. Safety and efficacy of pulmonary vein isolation using a circular, open-irrigated mapping and ablation catheter: A multicenter registry. Heart Rhythm. 2015;12(8):1782–1788. PubMed

Deneke T, et al. Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2014;25(4):339–345. PubMed

Vurma M, et al. Safety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation. Europace. 2016;18(8):1164–1169. PubMed

Rosso R, et al. Radiofrequency ablation of paroxysmal atrial fibrillation with the newirrigated multipolar nMARQablation catheter: verification of intracardiac signals with a second circular mapping catheter. Heart Rhythm. 2014;11(4):559–565. PubMed

Kiss A, et al. Cerebral microembolization during atrial fibrillation ablation: comparison of different single-shot ablation techniques. Int J Cardiol. 2014;174(2):276–281. PubMed

Gaita F, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol. 2011;22(9):961–968. PubMed

Herrera Siklody C, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58(7):681–688. PubMed

De Greef Y, et al. Duty-cycled multi-electrode radiofrequency vs. conventional irrigated point-by-point radiofrequency ablation for recurrent atrial fibrillation: comparative 3-year data. Europace. 2014;16(6):820–825. PubMed

McCready J, et al. Safety and efficacy of multipolar pulmonary vein ablation catheter vs. irrigated radiofrequency ablation for paroxysmal atrial fibrillation: a randomized multicentre trial. Europace. 2014;16(8):1145–1153. PubMed PMC

Wasmer K, et al. Safety profile of multielectrode-phased radiofrequency pulmonary vein ablation catheter and irrigated radiofrequency catheter. Europace. 2016;18(1):78–84. PubMed

Verma A, et al. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol. 2013;6(5):835–842. PubMed

Nagy-Balo E, et al. Predictors of cerebral microembolization during phased radiofrequency ablation of atrial fibrillation: analysis of biophysical parameters from the ablation generator. Heart Rhythm. 2014;11(6):977–983. PubMed

Zellerhoff S, et al. Modified phased radiofrequency ablation of atrial fibrillation reduces the number of cerebral microembolic signals. Europace. 2014;16(3):341–346. PubMed

De Greef Y, et al. Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial. Europace. 2016;18(5):687–695. PubMed PMC

Leitz P, et al. Data on procedural handling and complications of pulmonary vein isolation using the pulmonary vein ablation catheter GOLD(R) Europace. 2016;18(5):696–701. PubMed

Hummel J, et al. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014;11(2):202–209. PubMed

Boersma LV, et al. Multielectrode pulmonary vein isolation versus single tip wide area catheter ablation for paroxysmal atrial fibrillation: a multinational multicenter randomized clinical trial. Circ Arrhythm Electrophysiol. 2016;9(4):e003151. PubMed

Bourier F, et al. Sensor-Based Electromagnetic Navigation (Mediguide(R)): How Accurate Is It? A Phantom Model Study. J Cardiovasc Electrophysiol. 2015;26(10):1140–1145. PubMed

Nakagawa H, et al. Rapid high resolution electroanatomical mapping: evaluation of a new system in a canine atrial linear lesion model. Circ Arrhythm Electrophysiol. 2012;5(2):417–424. PubMed

Dong J, et al. Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation. 2006;113(2):186–194. PubMed

Kistler PM, et al. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(10):1093–1101. PubMed

Ector J, et al. Biplane three-dimensional augmented fluoroscopy as single navigation tool for ablation of atrial fibrillation: accuracy and clinical value. Heart Rhythm. 2008;5(7):957–964. PubMed

Sporton SC, et al. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15(3):310–315. PubMed

Estner HL, et al. Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX) Europace. 2006;8(8):583–587. PubMed

Scaglione M, et al. Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. Europace. 2011;13(7):955–962. PubMed

Martinek M, et al. Impact of integration of multislice computed tomography imaging into three-dimensional electroanatomic mapping on clinical outcomes, safety, and efficacy using radiofrequency ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2007;30(10):1215–1223. PubMed

Kistler PM, et al. The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J. 2008;29(24):3029–3036. PubMed

Bertaglia E, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace. 2009;11(8):1004–1010. PubMed

Della Bella P, et al. Image integration-guided catheter ablation of atrial fibrillation: a prospective randomized study. J Cardiovasc Electrophysiol. 2009;20(3):258–265. PubMed

Caponi D, et al. Ablation of atrial fibrillation: does the addition of threedimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome? A randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12(8):1098–1104. PubMed

Filgueiras-Rama D, et al. Remote magnetic navigation for accurate, real-time catheter positioning and ablation in cardiac electrophysiology procedures. J Vis Exp. 2013(74) PubMed PMC

Proietti R, et al. Remote magnetic with open-irrigated catheter vs. manual navigation for ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2013;15(9):1241–1248. PubMed

Wutzler A, et al. Robotic ablation of atrial fibrillation with a new remote catheter system. J Interv Card Electrophysiol. 2014;40(3):215–219. PubMed

Dello Russo A, et al. Analysis of catheter contact force during atrial fibrillation ablation using the robotic navigation system: results from a randomized study. J Interv Card Electrophysiol. 2016;46(2):97–103. PubMed

Faddis MN, et al. Novel, magnetically guided catheter for endocardial mapping and radiofrequency catheter ablation. Circulation. 2002;106(23):2980–2985. PubMed

Greenberg S, et al. Remote controlled magnetically guided pulmonary vein isolation in canines. Heart Rhythm. 2006;3(1):71–76. PubMed

Pappone C, et al. Robotic magnetic navigation for atrial fibrillation ablation. J Am Coll Cardiol. 2006;47(7):1390–1400. PubMed

Saliba W, et al. Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol. 2008;51(25):2407–2411. PubMed

Wazni OM, et al. Experience with the hansen robotic system for atrial fibrillation ablation–lessons learned and techniques modified: Hansen in the real world. J Cardiovasc Electrophysiol. 2009;20(11):1193–1196. PubMed

Bradfield J, et al. Catheter ablation utilizing remote magnetic navigation: a review of applications and outcomes. Pacing Clin Electrophysiol. 2012;35(8):1021–1034. PubMed

Hlivak P, et al. Robotic navigation in catheter ablation for paroxysmal atrial fibrillation: midterm efficacy and predictors of postablation arrhythmia recurrences. J Cardiovasc Electrophysiol. 2011;22(5):534–540. PubMed

Willems S, et al. Persistence of pulmonary vein isolation after robotic remotenavigated ablation for atrial fibrillation and its relation to clinical outcome. J Cardiovasc Electrophysiol. 2010;21(10):1079–1084. PubMed

Troianos CA, et al. Guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2011;24(12):1291–1318. PubMed

Wynn GJ, et al. Improving safety in catheter ablation for atrial fibrillation: a prospective study of the use of ultrasound to guide vascular access. J Cardiovasc Electrophysiol. 2014;25(7):680–685. PubMed

Saliba W, Thomas J. Intracardiac echocardiography during catheter ablation of atrial fibrillation. Europace. 2008;10(Suppl 3):iii42–47. PubMed

Ferguson JD, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol. 2009;2(6):611–619. PubMed PMC

Kim SS, et al. The use of intracardiac echocardiography and other intracardiac imaging tools to guide noncoronary cardiac interventions. J Am Coll Cardiol. 2009;53(23):2117–2128. PubMed

Schmidt M, et al. Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardiovasc Electrophysiol. 2010;21(11):1202–1207. PubMed

Packer DL, et al. New generation of electro-anatomic mapping: full intracardiac ultrasound image integration. Europace. 2008;10(Suppl 3):iii35–iii41. PubMed

Rostock T, et al. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. J Am Coll Cardiol. 2008;51(22):2153–2160. PubMed

Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol. 2004;43(10):1861–1867. PubMed

Vasamreddy CR, et al. Technique and results of pulmonary vein angiography in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(1):21–26. PubMed

Strohmer B, Schernthaner C, Pichler M. Simultaneous angiographic imaging of ipsilateral pulmonary veins for catheter ablation of atrial fibrillation. Clin Res Cardiol. 2006;95(11):591–599. PubMed

Fynn SP, Kalman JM. Pulmonary veins: anatomy, electrophysiology, tachycardia, and fibrillation. Pacing Clin Electrophysiol. 2004;27(11):1547–1559. PubMed

Walters TE, Ellims AH, Kalman JM. The role of left atrial imaging in the management of atrial fibrillation. Prog Cardiovasc Dis. 2015;58(2):136–151. PubMed

Lin WS, et al. Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation. 2000;101(11):1274–1281. PubMed

Tsao HM, et al. Role of right middle pulmonary vein in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2001;12(12):1353–1357. PubMed

Perez-Lugones A, et al. Three-dimensional reconstruction of pulmonary veins in patients with atrial fibrillation and controls: morphological characteristics of different veins. Pacing Clin Electrophysiol. 2003;26(1 Pt 1):8–15. PubMed

Schwartzman D, Lacomis J, Wigginton WG. Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol. 2003;41(8):1349–1357. PubMed

Lickfett L, et al. Characterization of a new pulmonary vein variant using magnetic resonance angiography: incidence, imaging, and interventional implications of the “right top pulmonary vein”. J Cardiovasc Electrophysiol. 2004;15(5):538–543. PubMed

Mansour M, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(4):387–393. PubMed

Chun KR, et al. The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009;30(6):699–709. PubMed PMC

Donal E, et al. EACVI/EHRA Expert Consensus Document on the role of multimodality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17(4):355–383. PubMed

Hadid C, et al. Value of intraprocedural radiologic rotational angiography in atrial fibrillation ablation. Comparison with other imaging techniques. Rev Esp Cardiol (Engl Ed) 2012;65(6):574–575. PubMed

Lehar F, et al. Comparison of clinical outcomes and safety of catheter ablation for atrial fibrillation supported by data from CT scan or three-dimensional rotational angiogram of left atrium and pulmonary veins. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(4):622–628. PubMed

Hauser TH, et al. Prognostic value of pulmonary vein size in prediction of atrial fibrillation recurrence after pulmonary vein isolation: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2015;17:49. PubMed PMC

Dewire J, et al. The association of pre-existing left atrial fibrosis with clinical variables in patients referred for catheter ablation of atrial fibrillation. Clin Med Insights Cardiol. 2014;8(Suppl 1):25–30. PubMed PMC

Kim RJ, et al. Relationship ofMRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002. PubMed

Kim RJ, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–1453. PubMed

Karim R, et al. Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the LA: an open-access grand challenge. J Cardiovasc Magn Reson. 2013;15:105. PubMed PMC

Khurram IM, et al. MRI evaluation of radiofrequency, cryothermal, and laser left atrial lesion formation in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2015;38(11):1317–1324. PubMed PMC

Khurram IM, et al. Left atrial LGE and arrhythmia recurrence following pulmonary vein isolation for paroxysmal and persistent AF. JACC Cardiovasc Imaging. 2016;9(2):142–148. PubMed PMC

Sramko M, et al. Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation. Int J Cardiol. 2015;179:351–357. PubMed

Spragg DD, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9(12):2003–2009. PubMed

Grothoff M, et al. MR imaging-guided electrophysiological ablation studies in humans with passive catheter tracking: initial results. Radiology. 2014;271(3):695–702. PubMed

Nazarian S, et al. Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation. 2008;118(3):223–229. PubMed PMC

Halperin HR, Kolandaivelu A. MRI-Guided Electrophysiology Intervention. Rambam Maimonides Med J. 2010;1(2):e0015. PubMed PMC

Vergara GR, et al. Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm. 2011;8(2):295–303. PubMed PMC

Scherr D, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(4):379–384. PubMed

Vazquez SR, Johnson SA, Rondina MT. Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res. 2010;126(2):e69–e77. PubMed PMC

Liu Y, et al. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation. Europace. 2016;18(9):1357–1365. PubMed

Noseworthy PA, et al. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: a propensity-matched study of 24,244 patients. Heart Rhythm. 2015;12(6):1154–1161. PubMed

Deneke T, et al. Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol. 2015;26(4):455–463. PubMed

Dorwarth U, et al. Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles. Pacing Clin Electrophysiol. 2003;26(7 Pt 1):1438–1445. PubMed

Maleki K, et al. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol. 2005;16(6):561–565. PubMed

Wazni OM, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol. 2005;16(6):576–581. PubMed

Shah D. Filamentous thrombi during left-sided sheath-assisted catheter ablations. Europace. 2010;12(12):1657–1658. PubMed

Sparks PB, et al. Left atrial “stunning” following radiofrequency catheter ablation of chronic atrial flutter. J Am Coll Cardiol. 1998;32(2):468–475. PubMed

Cappato R, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100–1105. PubMed

Abhishek F, et al. Effectiveness of a strategy to reduce major vascular complications from catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2011;30(3):211–215. PubMed

Hoyt H, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8(12):1869–1874. PubMed

Chilukuri K, et al. Transoesophageal echocardiography predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Europace. 2010;12(11):1543–1549. PubMed

Schernthaner C, et al. High incidence of echocardiographic abnormalities of the interatrial septum in patients undergoing ablation for atrial fibrillation. Echocardiography. 2013;30(4):402–406. PubMed

Yamamoto M, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging. 2014;7(2):337–343. PubMed

Puwanant S, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol. 2009;54(22):2032–2039. PubMed

McCready JW, et al. Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? Europace. 2010;12(7):927–932. PubMed

Gula LJ, et al. Impact of routine transoesophageal echocardiography on safety, outcomes, and cost of pulmonary vein ablation: inferences drawn from a decision analysis model. Europace. 2010;12(11):1550–1557. PubMed

Calkins H, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376(17):1627–1636. PubMed

Kapa S, et al. ECG-gated dual-source CT for detection of left atrial appendage thrombus in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2010;29(2):75–81. PubMed

Romero J, et al. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis. Circ Cardiovasc Imaging. 2013;6(2):185–194. PubMed

Gottlieb I, et al. Diagnostic accuracy of arterial phase 64-slice multidetector CT angiography for left atrial appendage thrombus in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2008;19(3):247–251. PubMed

Lazoura O, et al. A low-dose, dual-phase cardiovascular CT protocol to assess left atrial appendage anatomy and exclude thrombus prior to left atrial intervention. Int J Cardiovasc Imaging. 2016;32(2):347–354. PubMed

Saksena S, et al. A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study. Circ Arrhythm Electrophysiol. 2010;3(6):571–577. PubMed

Baran J, et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I Study. Circ Arrhythm Electrophysiol. 2013;6(6):1074–1081. PubMed

Ren JF, et al. Intracardiac echocardiographic diagnosis of thrombus formation in the left atrial appendage: a complementary role to transesophageal echocardiography. Echocardiography. 2013;30(1):72–80. PubMed

Anter E, et al. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014;11(11):1890–1897. PubMed

Sriram CS, et al. Detection of left atrial thrombus by intracardiac echocardiography in patients undergoing ablation of atrial fibrillation. J Interv Card Electrophysiol. 2015;43(3):227–236. PubMed

Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151. PubMed

Granger CB, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992. PubMed

Patel MR, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891. PubMed

Giugliano RP, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–2104. PubMed

Wazni OM, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116(22):2531–2534. PubMed

Schmidt M, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol. 2009;32(8):995–999. PubMed

Kwak JJ, et al. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(6):620–625. PubMed

Gopinath D, et al. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations. J Cardiovasc Electrophysiol. 2011;22(2):236–239. PubMed

Hakalahti A, et al. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace. 2011;13(5):640–645. PubMed

Di Biase L, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation. 2014;129(25):2638–2644. PubMed

Bassiouny M, et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(3):460–466. PubMed PMC

Bin Abdulhak AA, et al. Safety and efficacy of interrupted dabigatran for periprocedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2013;15(10):1412–1420. PubMed

Hohnloser SH, Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Europace. 2013;15(10):1407–1411. PubMed

Providencia R, et al. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation. Europace. 2014;16(8):1137–1144. PubMed

Winkle RA, et al. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban. Europace. 2014;16(10):1443–1449. PubMed PMC

Armbruster HL, et al. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Ann Pharmacother. 2015;49(3):278–284. PubMed

Calkins H, et al. RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy. Am J Cardiol. 2015;115(1):154–155. PubMed

Cappato R, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36(28):1805–1811. PubMed PMC

Phan K, et al. Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis. Int J Cardiol. 2015;185:209–213. PubMed

Pollack CV, Jr, et al. Idarucizumab for Dabigatran Reversal. N Engl J Med. 2015;373(6):511–520. PubMed

Siegal DM, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med. 2015;373(25):2413–2424. PubMed

Ren JF, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005;16(5):474–477. PubMed

Bruce CJ, et al. Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. 2008;22(3):211–219. PubMed

Asbach S, et al. Early heparin administration reduces risk for left atrial thrombus formation during atrial fibrillation ablation procedures. Cardiol Res Pract. 2011;2011:615087. PubMed PMC

Briceno DF, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression. J Cardiovasc Electrophysiol. 2016;27(6):683–693. PubMed

Lakshmanadoss U, K R, Kutinsky I, Williamson B, Wong W, Haines DE. Figure-of-eight suture for vascular hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation [abstract] Europace. 2015;15(Suppl 3):iii136–iii159. PubMed PMC

Chilukuri K, et al. Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2009;25(3):175–181. PubMed

Majeed A, et al. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res. 2012;129(2):146–151. PubMed

Connolly SJ, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806–817. PubMed

Mega JL, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366(1):9–19. PubMed

Daoud EG, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm. 2011;8(9):1416–1423. PubMed

Riley MP, et al. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment. J Cardiovasc Electrophysiol. 2014;25(6):591–596. PubMed

Saad EB, et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score </=3: a long-term outcome study. Circ Arrhythm Electrophysiol. 2011;4(5):615–621. PubMed

Yagishita A, et al. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation. Circ J. 2011;75(10):2343–2349. PubMed

Zuern CS, et al. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Pacing Clin Electrophysiol. 2015;38(6):688–693. PubMed

Tran VN, et al. Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2015;38(4):499–506. PubMed

Piccini JP, et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol. 2009;2(6):626–633. PubMed

Noseworthy PA, et al. Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation. J Am Heart Assoc. 2015;4(11) PubMed PMC

Sjalander S, et al. Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation. JAMA Cardiol. 2017;2(2):146–152. PubMed

Elkassabany N, et al. Anesthetic management of patients undergoing pulmonary vein isolation for treatment of atrial fibrillation using high-frequency jet ventilation. J Cardiothorac Vasc Anesth. 2012;26(3):433–438. PubMed

Santangeli P, Lin D. Catheter Ablation of Paroxysmal Atrial Fibrillation: Have We Achieved Cure with Pulmonary Vein Isolation? Methodist Debakey Cardiovasc J. 2015;11(2):71–75. PubMed PMC

Pappone C, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. 2004;109(22):2724–2726. PubMed

Cummings JE, et al. Brief communication: atrial-esophageal fistulas after radiofrequency ablation. Ann Intern Med. 2006;144(8):572–574. PubMed

Shah D, et al. Acute pyloric spasm and gastric hypomotility: an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol. 2005;46(2):327–330. PubMed

Lemola K, et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation. 2004;110(24):3655–3660. PubMed

Cummings JE, et al. Left atrial flutter following pulmonary vein antrumisolation with radiofrequency energy: linear lesions or repeat isolation. J Cardiovasc Electrophysiol. 2005;16(3):293–297. PubMed

Cummings JE, et al. Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the LA. Circulation. 2005;112(4):459–464. PubMed

Good E, et al. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2005;46(11):2107–2110. PubMed

Kottkamp H, et al. Topographic variability of the esophageal left atrial relation influencing ablation lines in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16(2):146–150. PubMed

Redfearn DP, et al. Esophageal temperature monitoring during radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16(6):589–593. PubMed

Ren JF, Marchlinski FE, Callans DJ. Real-time intracardiac echocardiographic imaging of the posterior left atrial wall contiguous to anterior wall of the esophagus. J Am Coll Cardiol. 2006;48(3):594. PubMed

Ruby RS, et al. Prevalence of fever in patients undergoing left atrial ablation of atrial fibrillation guided by barium esophagraphy. J Cardiovasc Electrophysiol. 2009;20(8):883–887. PubMed

Ripley KL, et al. Time course of esophageal lesions after catheter ablation with cryothermal and radiofrequency ablation: implication for atrio-esophageal fistula formation after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(6):642–646. PubMed

Ahmed H, et al. The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm. 2009;6(7):962–969. PubMed

Kawasaki R, et al. Atrioesophageal fistula complicating cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(7):787–792. PubMed

Lim HW, et al. Atrioesophageal fistula during cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):208–213. PubMed

Yokoyama K, et al. Canine model of esophageal injury and atrial-esophageal fistula after applications of forward-firing high-intensity focused ultrasound and side-firing unfocused ultrasound in the left atrium and inside the pulmonary vein. Circ Arrhythm Electrophysiol. 2009;2(1):41–49. PubMed

Singh SM, et al. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008;1(3):162–168. PubMed

Kuwahara T, et al. Safe and effective ablation of atrial fibrillation: importance of esophageal temperature monitoring to avoid periesophageal nerve injury as a complication of pulmonary vein isolation. J Cardiovasc Electrophysiol. 2009;20(1):1–6. PubMed

Contreras-Valdes FM, et al. Severity of esophageal injury predicts time to healing after radiofrequency catheter ablation for atrial fibrillation. Heart Rhythm. 2011;8(12):1862–1868. PubMed

Leite LR, et al. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures: results of a pilot study. Circ Arrhythm Electrophysiol. 2011;4(2):149–156. PubMed

Tschabrunn CM, et al. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015;17(6):891–897. PubMed

Deneke T, et al. Utility of esophageal temperature monitoring during pulmonary vein isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation. J Cardiovasc Electrophysiol. 2011;22(3):255–261. PubMed

Carroll BJ, et al. Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol. 2013;24(9):958–964. PubMed

Muller P, et al. Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm. 2015;12(7):1464–1469. PubMed

Tsuchiya T, et al. Atrial fibrillation ablation with esophageal cooling with a cooled water-irrigated intraesophageal balloon: a pilot study. J Cardiovasc Electrophysiol. 2007;18(2):145–150. PubMed

Arruda MS, et al. Feasibility and safety of using an esophageal protective system to eliminate esophageal thermal injury: implications on atrialesophageal fistula following AF ablation. J Cardiovasc Electrophysiol. 2009;20(11):1272–1278. PubMed

Kuwahara T, et al. Oesophageal cooling with ice water does not reduce the incidence of oesophageal lesions complicating catheter ablation of atrial fibrillation: randomized controlled study. Europace. 2014;16(6):834–839. PubMed

Kuwahara T, et al. Incidences of esophageal injury during esophageal temperature monitoring: a comparative study of a multi-thermocouple temperature probe and a deflectable temperature probe in atrial fibrillation ablation. J Interv Card Electrophysiol. 2014;39(3):251–257. PubMed

Chugh A, et al. Mechanical displacement of the esophagus in patients undergoing left atrial ablation of atrial fibrillation. Heart Rhythm. 2009;6(3):319–322. PubMed

Koruth JS, et al. Mechanical esophageal displacement during catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(2):147–154. PubMed

Zellerhoff S, Lenze F, Eckardt L. Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence? Europace. 2011;13(9):1219–1221. PubMed

Zellerhoff S, et al. Fatal course of esophageal stenting of an atrioesophageal fistula after atrial fibrillation ablation. Heart Rhythm. 2011;8(4):624–626. PubMed

Khan M, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007(2) CD003244. PubMed

Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008;359(16):1700–1707. PubMed PMC

Martinek M, et al. Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. Heart Rhythm. 2010;7(9):1224–1230. PubMed

Shaheen NJ, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41(3):588–594. PubMed

Halm U, et al. Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias. Am J Gastroenterol. 2010;105(3):551–556. PubMed

Knopp H, et al. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014;11(4):574–578. PubMed

Dagres N, et al. Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases. J Cardiovasc Electrophysiol. 2006;17(11):1213–1215. PubMed

Eitel C, et al. Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythm Electrophysiol. 2013;6(4):675–681. PubMed

Singh SM, et al. Clinical outcomes after repair of left atrial esophageal fistulas occurring after atrial fibrillation ablation procedures. Heart Rhythm. 2013;10(11):1591–1597. PubMed

Bunch TJ, et al. Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol. 2006;17(4):435–439. PubMed

Cappato R, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53(19):1798–1803. PubMed

Tan C, Coffey A. Atrioesophageal fistula after surgical unipolar radiofrequency atrial ablation for atrial fibrillation. Ann Thorac Surg. 2013;95(3):e61–e62. PubMed

Mohanty S. Outcomes of atrio-esophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. J Cardiovasc Electrophysiol. 2014;25(9):E6. PubMed

Mohanty S, et al. Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. J Cardiovasc Electrophysiol. 2014;25(6):579–584. PubMed

Hazell W, et al. Atrio-oesophageal fistula: an emergent complication of radiofrequency ablation. Emerg Med Australas. 2009;21(4):329–332. PubMed

Cazavet A, et al. Successful surgery for atrioesophageal fistula caused by transcatheter ablation of atrial fibrillation. J Thorac Cardiovasc Surg. 2010;140(3):e43–e45. PubMed

Podgaetz E, Deschamps C. Esophageal complications of catheter ablation for atrial fibrillation: a case report. J Thorac Cardiovasc Surg. 2013;145(1):e9–13. PubMed

Queneherve L, et al. Endoscopic management of an esophagopericardial fistula after radiofrequency ablation for atrial fibrillation. World J Gastroenterol. 2013;19(21):3352–3353. PubMed PMC

Gunes MF, et al. Ablating the posterior heart: cardioesophageal fistula complicating radiofrequency ablation in the coronary sinus. J Cardiovasc Electrophysiol. 2015;26(12):1376–1378. PubMed

Qadeer MA, et al. Endoscopic clips for closing esophageal perforations: case report and pooled analysis. Gastrointest Endosc. 2007;66(3):605–611. PubMed

Ellis CR, et al. Successful treatment of esophageal perforation following atrial fibrillation ablation with a fully covered esophageal stent: prevention of atrialesophageal fistula. Journal of Innovations in Cardiac Rhythm Management. 2012;3:874–878.

Markar SR, et al. Novel multimodality endoscopic closure of postoperative esophageal fistula. Int J Surg Case Rep. 2012;3(11):577–579. PubMed PMC

Cappato R, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38. PubMed

Deshmukh A, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128(19):2104–2112. PubMed

Gupta A, et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013;6(6):1082–1088. PubMed

Takahashi Y, et al. Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol. 2005;16(10):1104–1107. PubMed

Chilukuri K, et al. Association of transseptal punctures with isolated migraine aura in patients undergoing catheter ablation of cardiac arrhythmias. J Cardiovasc Electrophysiol. 2009;20(11):1227–1230. PubMed

Noheria A, et al. Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2011;30(3):227–232. PubMed

Barbhaiya CR, et al. Global survey of esophageal and gastric injury in atrial fibrillation ablation: incidence, time to presentation, and outcomes. J Am Coll Cardiol. 2015;65(13):1377–1378. PubMed

Holmes DR, Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009;2(4):267–276. PubMed

Fender EA, Packer DL, Holmes DR., Jr Pulmonary vein stenosis after atrial fibrillation ablation. EuroIntervention. 2016;12(Suppl X):X31–X34. PubMed

Kirchhof P, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options–a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2012;14(1):8–27. PubMed PMC

Oral H, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation. 2006;113(15):1824–1831. PubMed

Vasamreddy CR, et al. Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter. J Cardiovasc Electrophysiol. 2004;15(6):692–697. PubMed

Bertaglia E, et al. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin Electrophysiol. 2005;28(5):366–371. PubMed

Das M, et al. Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study. Circ Arrhythm Electrophysiol. 2015;8(4):846–852. PubMed

Kaitani K, et al. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial. Eur Heart J. 2016;37(7):610–618. PubMed

Willems S, et al. Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) trial. Circ Arrhythm Electrophysiol. 2016;9(8) PubMed

Klemm HU, et al. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2006;17(2):146–150. PubMed

Senatore G, et al. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2005;45(6):873–876. PubMed

Pokushalov E, et al. Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring. J Cardiovasc Electrophysiol. 2011;22(4):369–375. PubMed

Dagres N, et al. Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. Int J Cardiol. 2010;139(3):305–306. PubMed

Winkle RA, et al. Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablation. Am J Cardiol. 2012;110(6):840–844. PubMed

Kapa S, et al. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol. 2013;24(8):875–881. PubMed

Pecha S, et al. Concomitant surgical atrial fibrillation ablation and event recorder implantation: better monitoring, better outcome? Interact Cardiovasc Thorac Surg. 2013;16(4):465–469. PubMed PMC

Takagi T, et al. Role of extended external auto-triggered loop recorder monitoring for atrial fibrillation. Circ J. 2014;78(11):2637–2642. PubMed

Damiano RJ, Jr, et al. Detection of atrial fibrillation after surgical ablation: conventional versus continuous monitoring. Ann Thorac Surg. 2016;101(1):42–47. discussion 47–48. PubMed PMC

Piorkowski C, et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16(12):1286–1292. PubMed

Janse PA, et al. Symptoms versus objective rhythm monitoring in patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation. Eur J Cardiovasc Nurs. 2008;7(2):147–151. PubMed

Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm. 2006;3(12):1445–1452. PubMed

Edgerton JR, et al. Long-term monitoring after surgical ablation for atrial fibrillation: how much is enough? J Thorac Cardiovasc Surg. 2011;142(1):162–165. PubMed

Mulder AA, et al. Arrhythmia detection after atrial fibrillation ablation: value of incremental monitoring time. Pacing Clin Electrophysiol. 2012;35(2):164–169. PubMed

Gussak I, et al. Wireless remote monitoring of reconstructed 12-lead ECGs after ablation for atrial fibrillation using a hand-held device. J Electrocardiol. 2012;45(2):129–135. PubMed

Tarakji KG, et al. Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study. Heart Rhythm. 2015;12(3):554–559. PubMed

Hindricks G, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3(2):141–147. PubMed

Bogachev-Prokophiev A, et al. Assessment of concomitant paroxysmal atrial fibrillation ablation in mitral valve surgery patients based on continuous monitoring: does a different lesion set matter? Interact Cardiovasc Thorac Surg. 2014;18(2):177–181. discussion 182. PubMed PMC

Ad N, et al. The Cox-Maze III procedure success rate: comparison by electrocardiogram, 24-hour holter monitoring and long-term monitoring. Ann Thorac Surg. 2009;88(1):101–105. PubMed

Hanke T, et al. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation. 2009;120(11 Suppl):S177–S184. PubMed

Liu J, et al. The value of transtelephonic electrocardiogram monitoring system during the “Blanking Period” after ablation of atrial fibrillation. J Electrocardiol. 2010;43(6):667–672. PubMed

Bogachev-Prokophiev A, et al. Ablation for atrial fibrillation during mitral valve surgery: 1-year results through continuous subcutaneous monitoring. Interact Cardiovasc Thorac Surg. 2012;15(1):37–41. PubMed PMC

Pokushalov E, et al. Does atrial fibrillation burden measured by continuous monitoring during the blanking period predict the response to ablation at 12- month follow-up? Heart Rhythm. 2012;9(9):1375–1379. PubMed

Perez-Castellano N, et al. The COR trial: a randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation. Heart Rhythm. 2014;11(1):8–14. PubMed

Charitos EI, et al. Long-term outcomes after surgical ablation for atrial fibrillation in patients with continuous heart rhythm monitoring devices. Interact Cardiovasc Thorac Surg. 2015;21(6):712–721. PubMed

Pecha S, et al. Implantable loop recorder monitoring after concomitant surgical ablation for atrial fibrillation (AF): insights from more than 200 continuously monitored patients. Heart Vessels. 2016;31(8):1347–1353. PubMed

Eitel C, et al. Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace. 2011;13(4):480–485. PubMed PMC

Seidl K, et al. Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? Pacing Clin Electrophysiol. 1998;21(4 Pt 1):694–700. PubMed

Purerfellner H, et al. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol. 2004;27(7):983–992. PubMed

Martinek M, et al. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol. 2007;18(8):818–823. PubMed

Steven D, et al. What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J. 2008;29(8):1037–1042. PubMed

Puskas JD, et al. “Spot” ECGs underestimate atrial fibrillation recurrence after surgical ablation. Innovations (Phila) 2008;3(1):7–11. PubMed

Kaufman ES, et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm. 2012;9(8):1241–1246. PubMed

Arbelo E, et al. The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J. 2014;35(22):1466–1478. PubMed

O’Donnell D, et al. Delayed cure despite early recurrence after pulmonary vein isolation for atrial fibrillation. Am J Cardiol. 2003;91(1):83–85. PubMed

Jiang H, et al. Predictors of early recurrence and delayed cure after segmental pulmonary vein isolation for paroxysmal atrial fibrillation without structural heart disease. J Interv Card Electrophysiol. 2006;15(3):157–163. PubMed

Richter B, et al. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome. Am J Cardiol. 2008;101(6):843–847. PubMed

Reddy VY, et al. Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? Heart Rhythm. 2008;5(3):353–360. PubMed

Kirchhof P, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007;28(22):2803–2817. PubMed

Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021–2028. PubMed

Li XP, et al. Predictive value of early recurrence and delayed cure after catheter ablation for patients with chronic atrial fibrillation. Circ J. 2008;72(7):1125–1129. PubMed

Andrade JG, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35(1):106–116. PubMed

Mugnai G, et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: Predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences. Heart Rhythm. 2016;13(4):845–851. PubMed

Roux JF, et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study) Circulation. 2009;120(12):1036–1040. PubMed

Leong-Sit P, et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol. 2011;4(1):11–14. PubMed

Koyama T, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J Am Coll Cardiol. 2010;56(18):1463–1472. PubMed

Kim YR, et al. Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2015;8(6):1366–1372. PubMed

Abed HS, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–2060. PubMed

Imazio M, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–2295. PubMed

Deftereos S, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60(18):1790–1796. PubMed

Deftereos S, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11(4):620–628. PubMed

Chilukuri K, et al. Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(1):27–32. PubMed

Baman TS, et al. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome. J Cardiovasc Electrophysiol. 2009;20(12):1321–1325. PubMed

Malasana G, et al. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(7):761–766. PubMed

Sponga S, et al. Role of an aggressive rhythm control strategy on sinus rhythm maintenance following intra-operative radiofrequency ablation of atrial fibrillation in patients undergoing surgical correction of valvular disease. J Cardiol. 2012;60(4):316–320. PubMed

Sairaku A, et al. Learning curve for ablation of atrial fibrillation in medium-volume centers. J Cardiol. 2011;57(3):263–268. PubMed

Sairaku A, et al. How many electrical cardioversions should be applied for repetitive recurrences of atrial arrhythmias following ablation of persistent atrial fibrillation? Europace. 2011;13(12):1703–1708. PubMed

Lellouche N, et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol. 2008;19(6):599–605. PubMed

Lee SH, et al. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2004;10(3):221–226. PubMed

Thomas SP, Wallace EM, Ross DL. The effect of a residual isthmus of surviving tissue on conduction after linear ablation in atrial myocardium. J Interv Card Electrophysiol. 2000;4(1):273–281. PubMed

Oral H, Knight BP, Morady F. Left atrial flutter after segmental ostial radiofrequency catheter ablation for pulmonary vein isolation. Pacing Clin Electrophysiol. 2003;26(6):1417–1419. PubMed

Villacastin J, et al. Left atrial flutter after radiofrequency catheter ablation of focal atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(4):417–421. PubMed

Gerstenfeld EP, et al. Reentrant and nonreentrant focal left atrial tachycardias occur after pulmonary vein isolation. Heart Rhythm. 2005;2(11):1195–1202. PubMed

Gerstenfeld EP, Marchlinski FE. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm. 2007;4(3 Suppl):S65–S72. PubMed

Lim TW, et al. Atrial arrhythmias after single-ring isolation of the posterior left atrium and pulmonary veins for atrial fibrillation: mechanisms and management. Circ Arrhythm Electrophysiol. 2008;1(2):120–126. PubMed

Anousheh R, et al. Effect of mitral isthmus block on development of atrial tachycardia following ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2010;33(4):460–468. PubMed

Brooks AG, et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm. 2010;7(6):835–846. PubMed

Themistoclakis S, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008;5(5):679–685. PubMed

Nalliah CJ, et al. Clinical significance of early atrial arrhythmia type and timing after single ring isolation of the pulmonary veins. Europace. 2015;17(7):1038–1044. PubMed

Satomi K. Electrophysiological characteristics of atrial tachycardia after pulmonary vein isolation of atrial fibrillation. Circ J. 2010;74(6):1051–1058. PubMed

Jais P, et al. Flutter localized to the anterior left atrium after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(3):279–285. PubMed

Patel AM, et al. Atrial tachycardia after ablation of persistent atrial fibrillation: identification of the critical isthmus with a combination of multielectrode activation mapping and targeted entrainment mapping. Circ Arrhythm Electrophysiol. 2008;1(1):14–22. PubMed

Jais P, et al. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol. 2009;20(5):480–491. PubMed

Sauer WH, et al. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm. 2006;3(9):1024–1028. PubMed

Marchlinski FE, et al. Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping. J Cardiovasc Electrophysiol. 2003;14(4):358–365. PubMed

Choi JI, et al. Clinical significance of early recurrences of atrial tachycardia after atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2010;21(12):1331–1337. PubMed

Al-Hijji MA, et al. Trends and predictors of repeat catheter ablation for atrial fibrillation. Am Heart J. 2016;171(1):48–55. PubMed

Gerstenfeld EP, et al. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J Cardiovasc Electrophysiol. 2003;14(7):685–690. PubMed

Wasmer K, et al. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation. Clin Res Cardiol. 2016;105(9):738–743. PubMed

Bassiouny M, et al. Randomized study of persistent atrial fibrillation ablation: ablate in sinus rhythm versus ablate complex-fractionated atrial electrograms in atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(2):e003596. PubMed

Rolf S, Dagres N, Hindricks G. Voltage-based ablation: the growing evidence for the role of individually tailored substrate modification for atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):31–33. PubMed

Dumonceau JM, et al. Acute delayed gastric emptying after ablation of atrial fibrillation: treatment with botulinum toxin injection. Endoscopy. 2006;38(5):543. PubMed

Bunch TJ, et al. Vagus nerve injury after posterior atrial radiofrequency ablation. Heart Rhythm. 2008;5(9):1327–1330. PubMed

Kuwahara T, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24(8):847–851. PubMed

Miyazaki S, et al. Factors associated with periesophageal vagal nerve injury after pulmonary vein antrum isolation. J Am Heart Assoc. 2014;3(5):e001209. PubMed PMC

Chopra N, Shadchehr A. Achalasia cardia as a unique complication of pulmonary vein isolation. Heart Rhythm. 2014;11(12):2297–2299. PubMed

Bertaglia E, et al. Does catheter ablation cure atrial fibrillation? Singleprocedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace. 2010;12(2):181–187. PubMed

Sotomi Y, et al. Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace. 2013;15(11):1581–1586. PubMed

Steinberg JS, et al. Very long-term outcome after initially successful catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11(5):771–776. PubMed

Krittayaphong R, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai. 2003;86(Suppl 1):S8–S16. PubMed

Oral H, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934–941. PubMed

Pappone C, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340–2347. PubMed

Stabile G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study) Eur Heart J. 2006;27(2):216–221. PubMed

Forleo GB, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20(1):22–28. PubMed

Mont L, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) Eur Heart J. 2014;35(8):501–507. PubMed PMC

Skelly A, et al. Catheter ablation for treatment of atrial fibrillation. Rockville, MD: Agency for Healthcare Research and Quality; 2015. PubMed

Siontis KC, et al. Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: meta-analysis of quality of life, morbidity, and mortality. JACC: Clinical Electrophysiology. 2016;2(2):170–180. PubMed

Khaykin Y, et al. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study. J Cardiovasc Electrophysiol. 2009;20(1):7–12. PubMed

Cappato R, et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011;58(25):2696–2697. PubMed

Themistoclakis S, et al. Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries. J Cardiovasc Electrophysiol. 2014;25(10):1074–1081. PubMed

Zado E, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19(6):621–626. PubMed

Corrado A, et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol. 2008;19(8):807–811. PubMed

Tan HW, et al. Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians. Int J Cardiol. 2010;145(1):147–148. PubMed

Piccini JP, et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation. 2012;126(18):2200–2207. PubMed PMC

Hao SC, et al. Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J Interv Card Electrophysiol. 2012;35(2):173–182. PubMed

Guiot A, et al. Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2012;23(1):36–43. PubMed

Hsu LF, et al. Catheter ablation for atrial fibrillation in congestive HF. N Engl J Med. 2004;351(23):2373–2383. PubMed

Olivotto I, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–2524. PubMed

Providencia R, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart. 2016;102(19):1533–1543. PubMed

Chun KR, et al. Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry. Clin Res Cardiol. 2013;102(6):459–468. PubMed

Humphries KH, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation. 2001;103(19):2365–2370. PubMed

Ong L, et al. Gender differences and quality of life in atrial fibrillation: the mediating role of depression. J Psychosom Res. 2006;61(6):769–774. PubMed

Dagres N, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49(5):572–577. PubMed

Volgman AS, et al. Women with atrial fibrillation: Greater risk, less attention. Gend Med. 2009;6(3):419–432. PubMed

Balk EM, et al. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol. 2010;21(11):1208–1216. PubMed

Heist EK, et al. Predictors of atrial fibrillation termination and clinical success of catheter ablation of persistent atrial fibrillation. Am J Cardiol. 2012;110(4):545–551. PubMed

Zhang XD, et al. Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women. Pacing Clin Electrophysiol. 2013;36(10):1236–1244. PubMed

Forleo GB, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9(8):613–620. PubMed

Takigawa M, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013;168(3):1984–1991. PubMed

Beck H, Curtis AB. Sex differences in outcomes of ablation of atrial fibrillation. J Atr Fibrillation. 2014;6(6):76–82. PubMed PMC

Baman TS, et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(6):626–631. PubMed PMC

Hoyt H, et al. Demographic profile of patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(9):994–998. PubMed

Shah RU, et al. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59(2):143–149. PubMed PMC

Bertaglia E, et al. Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1069–1074. PubMed

Su W, et al. Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3000 procedures. Heart Rhythm. 2015;12(7):1658–1666. PubMed

Takami M, et al. Impact of freezing time and balloon size on the thermodynamics and isolation efficacy during pulmonary vein isolation using the second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8(4):836–845. PubMed

Furnkranz A, et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(8):840–844. PubMed

Di Giovanni G, et al. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol. 2014;25(8):834–839. PubMed

Liu J, et al. Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation. Pacing Clin Electrophysiol. 2015;38(1):129–135. PubMed

Khoueiry Z, et al. Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy. Europace. 2016;18(9):1343–1351. PubMed

Mugnai G, et al. Comparison of pulmonary vein isolation using cryoballoon versus conventional radiofrequency for paroxysmal atrial fibrillation. Am J Cardiol. 2014;113(9):1509–1513. PubMed

Cheng X, et al. The long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation: a meta-analysis. Int J Cardiol. 2015;181:297–302. PubMed

Jourda F, et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace. 2015;17(2):225–231. PubMed

Luik A, et al. Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study. Circulation. 2015;132(14):1311–1319. PubMed PMC

Squara F, et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicentre European evaluation. Europace. 2015;17(5):718–724. PubMed

Wasserlauf J, et al. Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2015;38(4):483–489. PubMed

Schmidt M, et al. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation–One-year outcome data. Heart Rhythm. 2016;13(4):836–844. PubMed

Ciconte G, et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the secondgeneration cryoballoon. Heart Rhythm. 2015;12(1):60–66. PubMed

Koektuerk B, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8(5):1073–1079. PubMed

Guhl EN, et al. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(4):423–427. PubMed

Straube F, et al. Cryoballoon ablation for persistent atrial fibrillation—Large single-center experience. J Cardiol. 2016;68(6):492–497. PubMed

Su WW, et al. Novel usage of the cryoballoon catheter to achieve large area atrial substrate modification in persistent and long-standing persistent atrial fibrillation. J Interv Card Electrophysiol. 2016;46(3):275–285. PubMed

Ciconte G, et al. Circumferential pulmonary vein isolation as index procedure for persistent atrial fibrillation: a comparison between radiofrequency catheter ablation and second-generation cryoballoon ablation. Europace. 2015;17(4):559–565. PubMed

Spitzer SG, et al. Treatment of Recurrent Nonparoxysmal Atrial Fibrillation Using Focal Impulse and Rotor Mapping (FIRM)-Guided Rotor Ablation: Early Recurrence and Long-Term Outcomes. J Cardiovasc Electrophysiol. 2017;28(1):31–38. PubMed

Berntsen RF, et al. Focal impulse and rotor modulation as a stand-alone procedure for the treatment of paroxysmal atrial fibrillation: A within-patient controlled study with implanted cardiac monitoring. Heart Rhythm. 2016;13(9):1768–1774. PubMed

Lo LW, et al. Pearls and Pitfalls in Catheter Ablation of Persistent Atrial Fibrillation. Circ J. 2016;80(2):306–313. PubMed

Perrotta L, et al. How to learn pulmonary vein isolation with a novel ablation device: learning curve effects using the endoscopic ablation system. J Cardiovasc Electrophysiol. 2014;25(12):1293–1298. PubMed

Sediva L, et al. Visually guided laser ablation: a single-centre long-term experience. Europace. 2014;16(12):1746–1751. PubMed

Gal P, et al. First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation. Neth Heart J. 2015;23(2):96–99. PubMed PMC

Osca J, et al. Electrical Isolation of Pulmonary Veins Using Laser Catheter in the Treatment of Paroxysmal and Persistent Atrial Fibrillation. One-year Results. Rev Esp Cardiol (Engl Ed) 2016;69(5):488–493. PubMed

Sawhney N, et al. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol. 2009;104(3):366–372. PubMed PMC

Medi C, et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol. 2011;22(2):137–141. PubMed

Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008;19(7):762–768. PubMed PMC

Ware JE, et al. SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Center; 1993.

Bubien RS, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94(7):1585–1591. PubMed

Walfridsson H, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Europace. 2015;17(2):215–221. PubMed

Thrall G, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448 e1–448 e19. PubMed

Berkowitsch A, et al. Comparison of generic health survey SF-36 and arrhythmia related symptom severity check list in relation to post-therapy AF recurrence. Europace. 2003;5(4):351–355. PubMed

Reynolds MR, et al. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes. 2010;3(6):615–623. PubMed

Spertus J, et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(1):15–25. PubMed

Walfridsson U, Arestedt K, Stromberg A. Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden. Health Qual Life Outcomes. 2012;10:44. PubMed PMC

Fichtner S, et al. Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(2):121–127. PubMed

Kistler PM, et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44(1):109–116. PubMed

Wijffels MC, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96(10):3710–3720. PubMed

Scharf C, et al. Anatomy of the pulmonary veins in patients with atrial fibrillation and effects of segmental ostial ablation analyzed by computed tomography. J Cardiovasc Electrophysiol. 2003;14(2):150–155. PubMed

Jayam VK, et al. Atrial volume reduction following catheter ablation of atrial fibrillation and relation to reduction in pulmonary vein size: an evaluation using magnetic resonance angiography. J Interv Card Electrophysiol. 2005;13(2):107–114. PubMed

Tsao HM, et al. Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fibrillation: insight from long-term follow-up of three-dimensional magnetic resonance imaging. J Cardiovasc Electrophysiol. 2005;16(1):7–12. PubMed

Canpolat U, et al. The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2015;44(2):131–139. PubMed

Lemola K, et al. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm. 2005;2(9):923–928. PubMed

Verma A, et al. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis. J Cardiovasc Electrophysiol. 2006;17(7):741–746. PubMed

Jeevanantham V, et al. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010;105(9):1317–1326. PubMed

Machino-Ohtsuka T, et al. Significant improvement of left atrial and left atrial appendage function after catheter ablation for persistent atrial fibrillation. Circ J. 2013;77(7):1695–1704. PubMed

Muellerleile K, et al. Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(7):762–767. PubMed

Hanazawa K, et al. Effect of radiofrequency catheter ablation of persistent atrial fibrillation on the left atrial function: assessment by 320-row multislice computed tomography. Int J Cardiol. 2015;179:449–454. PubMed

Cochet H, et al. Atrial structure and function 5 years after successful ablation for persistent atrial fibrillation: an MRI study. J Cardiovasc Electrophysiol. 2014;25(7):671–679. PubMed

Gibson DN, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011;8(9):1364–1371. PubMed

Reynolds MR, et al. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis. Circ Cardiovasc Qual Outcomes. 2012;5(2):171–181. PubMed

Chang CH, et al. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis. Circ Arrhythm Electrophysiol. 2014;7(1):76–82. PubMed

Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016;37(31):2478–2487. PubMed

Abecasis J, et al. Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation. Europace. 2009;11(10):1289–1294. PubMed

McCready JW, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Europace. 2011;13(3):355–361. PubMed

D’Ascenzo F, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation? A meta-analysis. Int J Cardiol. 2013;167(5):1984–1989. PubMed

Chan P, et al. Cost-effectiveness of left atrial catheter ablation, antiarrhythmic therapy, and rate control therapy for paroxysmal and chronic atrial fibrillation [abstract] Circulation. 2005:e318. PubMed

Eckard N, et al. Cost-effectiveness of catheter ablation for patients with symptomatic atrial fibrillation. J Atr Fibrillation. 2009;2(2):15–24. PubMed PMC

Reynolds MR, et al. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2(4):362–369. PubMed PMC

Martin-Doyle W, Reynolds MR. Is AF ablation cost effective? J Atr Fibrillation. 2010;2(1):727–739. PubMed PMC

Assasi N, et al. Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses. CADTH Technol Overv. 2012;2(1):e2101. PubMed PMC

Neyt M, Van Brabandt H, Devos C. The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations. BMC Cardiovasc Disord. 2013;13:78. PubMed PMC

Reynolds MR, et al. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation. Europace. 2014;16(5):652–659. PubMed

Aronsson M, et al. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRAPAF substudy. Europace. 2015;17(1):48–55. PubMed

Winkle RA, et al. Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation. J Interv Card Electrophysiol. 2013;36(2):157–165. PubMed PMC

Ladapo JA, et al. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol. 2012;23(1):1–8. PubMed

McKenna C, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart. 2009;95(7):542–549. PubMed

Adragao PP, et al. Safety and long-term outcomes of catheter ablation of atrial fibrillation using magnetic navigation versus manual conventional ablation: a propensity-score analysis. J Cardiovasc Electrophysiol. 2016;27(Suppl 1):S11–S16. PubMed

Anderson JL, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(21):2304–2322. PubMed

Eick OJ, Gerritse B, Schumacher B. Popping phenomena in temperature-controlled radiofrequency ablation: when and why do they occur? Pacing Clin Electrophysiol. 2000;23(2):253–258. PubMed

Fisher JD, et al. Internal transcardiac pericardiocentesis for acute tamponade. Am J Cardiol. 2000;86(12):1388–1389, A6. PubMed

Hsu LF, et al. Transcardiac pericardiocentesis: anemergency life-saving technique for cardiac tamponade. J Cardiovasc Electrophysiol. 2003;14(9):1001–1003. PubMed

Bunch TJ, et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol. 2005;16(11):1172–1179. PubMed

Hsu LF, et al. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S106–S109. PubMed

Nairooz R, et al. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015;187:426–429. PubMed

Latchamsetty R, et al. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm. 2011;8(6):805–808. PubMed

Wu S, et al. Meta-analysis of efficacy and safety of new oral anticoagulants compared with uninterrupted vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2016;117(6):926–934. PubMed

Michowitz Y, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results froma worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2014;7(2):274–280. PubMed

Tsang TS, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77(5):429–436. PubMed

O’Neill MD, et al. Two techniques to avoid surgery for cardiac tamponade occurring during catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(3):323–325. PubMed

Katz ES, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000;36(2):468–471. PubMed

Di Biase L, et al. Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. J Am Coll Cardiol. 2006;48(12):2493–2499. PubMed

Prieto LR, et al. Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation. J Cardiovasc Electrophysiol. 2008;19(7):673–678. PubMed

Packer DL, et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation. 2005;111(5):546–554. PubMed

Taylor GW, et al. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation. 2000;101(14):1736–1742. PubMed

Arentz T, et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J. 2003;24(10):963–969. PubMed

Tse HF, et al. Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis. J Am Coll Cardiol. 2003;42(4):752–758. PubMed

Kasper L, et al. Hemoptysis and lung disease as a manifestation of pulmonary vein stenosis after cryoballoon catheter ablation for atrial fibrillation. Pol Arch Med Wewn. 2016;126(1-2):94–96. PubMed

Dong J, et al. Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging. J Cardiovasc Electrophysiol. 2005;16(8):845–852. PubMed

Hoyt RH, et al. Transvenous catheter cryoablation for treatment of atrial fibrillation: results of a feasibility study. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S78–S82. PubMed

Saad EB, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med. 2003;138(8):634–638. PubMed

Hilbert S, et al. Pulmonary vein collateral formation as a long-term result of post-interventional pulmonary vein stenosis. Eur Heart J. 2016;37(31):2474. PubMed

Hilbert S, Sommer P, Bollmann A. Pulmonary vein dilatation in a case of total pulmonary vein occlusion: contemporary approach using a combination of 3Dmapping system and image integration. Catheter Cardiovasc Interv. 2016;88(7):E227–E232. PubMed

Fender EA, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation. 2016;134(23):1812–1821. PubMed

De Potter TJ, et al. Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation. Europace. 2011;13(1):57–61. PubMed

Kanter KR, Kirshbom PM, Kogon BE. Surgical repair of pulmonary venous stenosis: a word of caution. Ann Thorac Surg. 2014;98(5):1687–1691. discussion 1691–1692. PubMed

Patel NS, et al. Successful surgical repair of iatrogenic pulmonary vein stenosis. J Cardiovasc Electrophysiol. 2012;23(6):656–658. PubMed

Bharat A, et al. Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis. J Heart Lung Transplant. 2013;32(6):621–625. PubMed

Ponamgi SP, et al. Catheter-based intervention for pulmonary vein stenosis due to fibrosing mediastinitis: the Mayo Clinic experience. Int J Cardiol Heart Vasc. 2015;8:103–107. PubMed PMC

Kumar S, et al. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5(4):701–705. PubMed

Gillinov AM, Pettersson G, Rice TW. Esophageal injury during radiofrequency ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2001;122(6):1239–1240. PubMed

Mohr FW, et al. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg. 2002;123(5):919–927. PubMed

Doll N, et al. Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg. 2003;125(4):836–842. PubMed

Sonmez B, et al. A fatal complication due to radiofrequency ablation for atrial fibrillation: atrio-esophageal fistula. Ann Thorac Surg. 2003;76(1):281–283. PubMed

Scanavacca MI, et al. Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(8):960–962. PubMed

Borchert B, et al. Lethal atrioesophageal fistula after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) Heart Rhythm. 2008;5(1):145–148. PubMed

Ghia KK, et al. A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol. 2009;24(1):33–36. PubMed

Gilcrease GW, Stein JB. A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(6):708–711. PubMed

Stockigt F, et al. Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol. 2012;23(11):1254–1257. PubMed

Yousuf O, Calkins H. Sounding the warning on the potential for oesophageal injury resulting from use of the nMARQ for ablation of atrial fibrillation. Europace. 2015;17(3):343–344. PubMed

Jackson, et al. The vagus plays a role in the anti-reflux barrier by controlling both the lower esophageal sphincter pressure and crural diaphragm activity. J Am Coll Surg. 2005;201((3)(Suppl)):S11.

Nolker G, et al. Esophageal acid levels after pulmonary vein isolation for atrial fibrillation. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S228–S230. PubMed

Medeiros De Vasconcelos JT, et al. Atrial-oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists. Europace. 2017;19(2):250–258. PubMed

Rillig A, et al. Modified energy settings are mandatory to minimize oesophageal injury using the novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. Europace. 2015;17(3):396–402. PubMed

Chavez P, et al. Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports. Open Heart. 2015;2(1):e000257. PubMed PMC

Mateos JC, et al. Simplified method for esophagus protection during radiofrequency catheter ablation of atrial fibrillation–prospective study of 704 cases. Rev Bras Cir Cardiovasc. 2015;30(2):139–147. PubMed PMC

Shim HB, et al. Successful management of atrio-esophageal fistula after cardiac radiofrequency catheter ablation. Korean J Thorac Cardiovasc Surg. 2013;46(2):142–145. PubMed PMC

Schwartz TW, et al. Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet. 1976;1(7969):1102–1105. PubMed

Ajaj W, et al. Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders. Gut. 2004;53(9):1256–1261. PubMed PMC

Pisani CF, et al. Gastric hypomotility following epicardial vagal denervation ablation to treat atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(2):211–213. PubMed

Kanaeda T, et al. Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test. J Arrhythm. 2015;31(6):364–370. PubMed PMC

Lo LW, et al. A novel finding—impairment of gastric myoelectricity after catheter ablation of atrial fibrillation. Circ J. 2013;77(8):2014–2023. PubMed

Janssens J, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322(15):1028–1031. PubMed

Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol. 2003;98(10):2122–2129. PubMed

Earley MJ, et al. Radiofrequency ablation of arrhythmias guided by nonfluoroscopic catheter location: a prospective randomized trial. Eur Heart J. 2006;27(10):1223–1229. PubMed

Sarabanda AV, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. 2005;46(10):1902–1912. PubMed

Guiot A, et al. Collateral nervous damages after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol. 2012;23(4):346–351. PubMed

Metzner A, et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol. 2014;25(5):466–470. PubMed

Okumura Y, et al. Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. J Cardiovasc Electrophysiol. 2009;20(10):1151–1157. PubMed

Arruda M, et al. Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. J Cardiovasc Electrophysiol. 2007;18(12):1261–1266. PubMed

Miyazaki S, et al. Prevalence and clinical outcome of phrenic nerve injury during superior vena cava isolation and circumferential pulmonary vein antrum isolation using radiofrequency energy. Am Heart J. 2014;168(6):846–853. PubMed

Wissner E, et al. Catheter ablation of atrial fibrillation in patients with persistent left superior vena cava is associated with major intraprocedural complications. Heart Rhythm. 2010;7(12):1755–1760. PubMed

Elayi CS, et al. Left superior vena cava isolation in patients undergoing pulmonary vein antrum isolation: impact on atrial fibrillation recurrence. Heart Rhythm. 2006;3(9):1019–1023. PubMed

Liu H, et al. Electrogram-guided isolation of the left superior vena cava for treatment of atrial fibrillation. Europace. 2007;9(9):775–780. PubMed

Yong Ji S, et al. Phrenic nerve injury: An underrecognized and potentially preventable complication of pulmonary vein isolation using a wide-area circumferential ablation approach. J Cardiovasc Electrophysiol. 2013;24(10):1086–1091. PubMed

Franceschi F, et al. Phrenic nerve monitoring with diaphragmatic electromyography during cryoballoon ablation for atrial fibrillation: the first human application. Heart Rhythm. 2011;8(7):1068–1071. PubMed

Miyazaki S, et al. Prospective evaluation of bilateral diaphragmatic electromyograms during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26(6):622–628. PubMed

Mondesert B, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(4):605–611. PubMed

Sacher F, et al. Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol. 2006;47(12):2498–2503. PubMed

Andrade JG, et al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. J Cardiovasc Electrophysiol. 2014;25(2):187–194. PubMed

Patel D, et al. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(4):412–417. PubMed

Kochhauser S, et al. Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens. Can J Cardiol. 2014;30(12):1541–1546. PubMed

Kosiuk J, et al. Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm. 2014;11(11):1934–1940. PubMed

Merchant FM, Delurgio DB. Catheter ablation of atrial fibrillation and risk of asymptomatic cerebral embolism. Pacing Clin Electrophysiol. 2014;37(3):389–397. PubMed

Lickfett L, et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol. 2006;17(1):1–7. PubMed

Gaita F, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122(17):1667–1673. PubMed

Schrickel JW, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace. 2010;12(1):52–57. PubMed

Deneke T, et al. Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm. 2011;8(11):1705–1711. PubMed

Sauren LD, et al. Transcranial measurement of cerebral microembolic signals during endocardial pulmonary vein isolation: comparison of three different ablation techniques. J Cardiovasc Electrophysiol. 2009;20(10):1102–1107. PubMed

Wieczorek M, et al. Investigation into causes of abnormal cerebral MRI findings following PVAC duty-cycled, phased RF ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(2):121–128. PubMed

Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol. 2006;5(4):364–372. PubMed

Kruis RW, Vlasveld FA, Van Dijk D. The (un)importance of cerebral microemboli. Semin Cardiothorac Vasc Anesth. 2010;14(2):111–118. PubMed

Medi C, et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62(6):531–539. PubMed

Ichiki H, et al. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Pacing Clin Electrophysiol. 2013;36(11):1328–1335. PubMed

Nagy-Balo E, et al. Transcranial measurement of cerebral microembolic signals during pulmonary vein isolation: a comparison of two ablation techniques. Circ Arrhythm Electrophysiol. 2013;6(3):473–480. PubMed

Vermeer SE, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–1222. PubMed

Helps SC, et al. The effect of gas emboli on rabbit cerebral blood flow. Stroke. 1990;21(1):94–99. PubMed

Krivonyak GS, Warren SG. Cerebral arterial air embolism treated by a vertical head-down maneuver. Catheter Cardiovasc Interv. 2000;49(2):185–187. PubMed

Cauchemez B, et al. High-flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the LA. J Cardiovasc Electrophysiol. 2004;15(3):276–283. PubMed

Kuwahara T, et al. Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation: lessons from five cases. Europace. 2012;14(2):204–208. PubMed

Franzen OW, et al. Mechanisms underlying air aspiration in patients undergoing left atrial catheterization. Catheter Cardiovasc Interv. 2008;71(4):553–558. PubMed

Ryu KH, et al. Heparin reduces neurological impairment after cerebral arterial air embolism in the rabbit. Stroke. 1996;27(2):303–309. discussion 310. PubMed

Aldhoon B, et al. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace. 2013;15(1):24–32. PubMed

Mugnai G, et al. Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients. Int J Cardiol. 2015;196:42–49. PubMed

Murakawa Y, et al. Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-A report on periprocedural oral anticoagulants. J Arrhythm. 2015;31(1):29–32. PubMed PMC

Palaniswamy C, et al. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and inhospital mortality in the United States. Heart Rhythm. 2014;11(11):2056–2063. PubMed

Peichl P, et al. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol. 2014;7(4):684–690. PubMed

Waigand J, et al. Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Catheter Cardiovasc Interv. 1999;47(2):157–164. PubMed

Lakkireddy D, et al. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol. 2014;63(10):982–988. PubMed

Tanaka-Esposito CC, et al. Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol. 2013;37(2):163–168. PubMed PMC

Errahmouni A, et al. Ultrasound-guided venous puncture in electrophysiological procedures: a safe method, rapidly learned. Pacing Clin Electrophysiol. 2014;37(8):1023–1028. PubMed

Chugh A, et al. Manifestations of coronary arterial injury during catheter ablation of atrial fibrillation and related arrhythmias. Heart Rhythm. 2013;10(11):1638–1645. PubMed

Makimoto H, et al. Aborted sudden cardiac death due to radiofrequency ablation within the coronary sinus and subsequent total occlusion of the circumflex artery. J Cardiovasc Electrophysiol. 2013;24(8):929–932. PubMed

Kitamura T, et al. Transient sinus node dysfunction following sinus node artery occlusion due to radiofrequency catheter ablation of the septal superior vena cava-right atrium junction. J Electrocardiol. 2016;49(1):18–22. PubMed

Ouali S, et al. Acute coronary occlusion during radiofrequency catheter ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2002;13(10):1047–1049. PubMed

Mykytsey A, et al. Right coronary artery occlusion during RF ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2010;21(7):818–821. PubMed

Sticherling C, Pfister O, Osswald S. Thrombo-embolic occlusion of the left anterior descending coronary artery complicating left atrial radiofrequency ablation. Europace. 2009;11(1):117–118. PubMed

Wong KC, et al. High incidence of acute sub-clinical circumflex artery ‘injury’ following mitral isthmus ablation. Eur Heart J. 2011;32(15):1881–1890. PubMed

Fayad G, et al. Circumflex artery stenosis induced by intraoperative radiofrequency ablation. Ann Thorac Surg. 2003;76(4):1291–1293. PubMed

Calkins H, et al. Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections. Circulation. 1991;84(6):2376–2382. PubMed

Lindsay BD, et al. Radiation exposure to patients and medical personnel during radiofrequency catheter ablation for supraventricular tachycardia. Am J Cardiol. 1992;70(2):218–223. PubMed

Kovoor P, et al. Risk to patients from radiation associated with radiofrequency ablation for supraventricular tachycardia. Circulation. 1998;98(15):1534–1540. PubMed

Macle L, et al. Radiation exposure during radiofrequency catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2003;26(1 Pt 2):288–291. PubMed

Lickfett L, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110(19):3003–3010. PubMed

Ector J, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2007;50(3):234–242. PubMed

Chen J, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol. 2010;56(9):702–711. PubMed PMC

Khaykin Y, et al. CARTO-guided vs. NavX-guided pulmonary vein antrum isolation and pulmonary vein antrum isolation performed without 3-D mapping: effect of the 3-D mapping system on procedure duration and fluoroscopy time. J Interv Card Electrophysiol. 2011;30(3):233–240. PubMed

Stabile G, et al. Reduced fluoroscopy exposure during ablation of atrial fibrillation using a novel electroanatomical navigation system: a multicentre experience. Europace. 2012;14(1):60–65. PubMed

De Ponti R, et al. Simulator training reduces radiation exposure and improves trainees’ performance in placing electrophysiologic catheters during patientbased procedures. Heart Rhythm. 2012;9(8):1280–1285. PubMed

Kleemann T, et al. Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. Clin Res Cardiol. 2016;105(10):858–864. PubMed

Steven D, et al. Reduced fluoroscopy during atrial fibrillation ablation: benefits of robotic guided navigation. J Cardiovasc Electrophysiol. 2010;21(1):6–12. PubMed

Weiss JP, et al. A comparison of remote magnetic irrigated tip ablation versus manual catheter irrigated tip catheter ablation with and without force sensing feedback. J Cardiovasc Electrophysiol. 2016;27(Suppl 1):S5–S10. PubMed

Dragusin O, et al. Evaluation of a radiation protection cabin for invasive electrophysiological procedures. Eur Heart J. 2007;28(2):183–189. PubMed

Reddy VY, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11):1644–1653. PubMed

Bulava A, Hanis J, Eisenberger M. Catheter ablation of atrial fibrillation using zero-fluoroscopy technique: a randomized trial. Pacing Clin Electrophysiol. 2015;38(7):797–806. PubMed

Stabile G, et al. Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: a multicentre registry. Europace. 2014;16(8):1154–1159. PubMed

Luckie M, et al. Dressler’s syndrome following pulmonary vein isolation for atrial fibrillation. Acute Card Care. 2008;10(4):234–235. PubMed

Lambert T, et al. Cardiac tamponade following pericarditis 18 days after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2010;99(9):595–597. PubMed

Torihashi S, et al. Two cases of delayed cardiac tamponade due to pericarditis after pulmonary vein (PV) isolation for atrial fibrillation. Intern Med. 2015;54(7):791–796. PubMed

Kim DR, et al. Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation. Yonsei Med J. 2015;56(2):324–331. PubMed PMC

Kesek M, et al. Entrapment of circular mapping catheter in the mitral valve. Heart Rhythm. 2007;4(1):17–19. PubMed

Tavernier R, Duytschaever M, Taeymans Y. Fracture of a circular mapping catheter after entrapment in the mitral valve apparatus during segmental pulmonary vein isolation. Pacing Clin Electrophysiol. 2003;26(8):1774–1775. PubMed

Grove R, et al. Demand for open heart surgery due to entrapment of a circular mapping catheter in the mitral valve in a patient undergoing atrial fibrillation ablation. Clin Res Cardiol. 2008;97(9):628–629. PubMed

Lakkireddy D, et al. Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm. 2011;8(7):975–980. PubMed

Zeljko HM, et al. Entrapment of the circular mapping catheter in the mitral valve in two patients undergoing atrial fibrillation ablation. Europace. 2011;13(1):132–133. PubMed

Desimone CV, et al. Catheter ablation related mitral valve injury: the importance of early recognition and rescue mitral valve repair. J Cardiovasc Electrophysiol. 2014;25(9):971–975. PubMed PMC

Gurbuz O, et al. Case report: paravalvular leak as a complication of percutaneous catheter ablation for atrial fibrillation. J Cardiothorac Surg. 2014;9:187. PubMed PMC

Mansour M, et al. Successful release of entrapped circumferential mapping catheters in patients undergoing pulmonary vein isolation for atrial fibrillation. Heart Rhythm. 2004;1(5):558–561. PubMed

Shoemaker MB, et al. Left atrial hypertension after repeated catheter ablations for atrial fibrillation. J Am Coll Cardiol. 2011;57(19):1918–1919. PubMed

Welch TD, et al. Symptomatic pulmonary hypertension with giant left atrial v waves after surgical maze procedures: evaluation by comprehensive hemodynamic catheterization. Heart Rhythm. 2013;10(12):1839–1842. PubMed

Witt C, et al. Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the “stiff left atrial syndrome”. Catheter Cardiovasc Interv. 2013;82(5):E747–E749. PubMed

Pilote L, et al. Stiff left atrial syndrome. Can J Cardiol. 1988;4(6):255–257. PubMed

Khurram IM, et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ Arrhythm Electrophysiol. 2016;9(3) PubMed

Kosiuk J, et al. Prevalence and predictors of worsened left ventricular diastolic dysfunction after catheter ablation of atrial fibrillation. Int J Cardiol. 2013;168(4):3613–3615. PubMed

Wong GR, et al. Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation ‘stiff left atrial syndrome’. Int J Cardiol. 2015;181:55–56. PubMed

Aryana A, et al. Impact of Pulmonary Vein Cryoballoon Ablation on Bronchial Injury. J Cardiovasc Electrophysiol. 2016;27(7):861–867. PubMed

Verma N, et al. Ice formation in the left mainstem bronchus during cryoballoon ablation for the treatment of atrial fibrillation. Heart Rhythm. 2016;13(3):814–815. PubMed

Kang KW, et al. Long-term changes in heart rate variability after radiofrequency catheter ablation for atrial fibrillation: 1-year follow-up study with irrigation tip catheter. J Cardiovasc Electrophysiol. 2014;25(7):693–700. PubMed

Bunch TJ, et al. Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol. 2005;16(12):1318–1325. PubMed

Bai R, et al. Phrenic nerve injury after catheter ablation: should we worry about this complication? J Cardiovasc Electrophysiol. 2006;17(9):944–948. PubMed

De Ponti R, et al. Superiority of simulator-based training compared with conventional training methodologies in the performance of transseptal catheterization. J Am Coll Cardiol. 2011;58(4):359–363. PubMed

Talbot H, et al. Interactive training system for interventional electrocardiology procedures. Med Image Anal. 2016;35:225–237. PubMed

Zipes DP, et al. 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (a revision of the ACC/AHA 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion) J Am Coll Cardiol. 2015;66(24):2767–2802. PubMed

Wojcik M, et al. Learning curve in cryoballoon ablation of atrial fibrillation: eight-year experience. Circ J. 2014;78(7):1612–1618. PubMed

Martirosyan M, et al. Learning curve in circular multipolar phased radiofrequency ablation of atrial fibrillation. Cardiol J. 2015;22(3):260–266. PubMed

Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118(5):833–840. PubMed

Feinberg MS, et al. Restoration of atrial function after the maze procedure for patients with atrial fibrillation. Assessment by Doppler echocardiography. Circulation. 1994;90(5 Pt 2):II285–II292. PubMed

Prasad SM, et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126(6):1822–1828. PubMed

U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data: AtriCure Synergy Ablation System. PMA P100046. 2011

Demaria RG, et al. Surgical radiofrequency ablation induces coronary endothelial dysfunction in porcine coronary arteries. Eur J Cardiothorac Surg. 2003;23(3):277–282. PubMed

Laczkovics A, Khargi K, Deneke T. Esophageal perforation during left atrial radiofrequency ablation. J Thorac Cardiovasc Surg. 2003;126(6):2119–2120. PubMed

Doll N, et al. Epicardial treatment of atrial fibrillation using cryoablation in an acute off-pump sheep model. Thorac Cardiovasc Surg. 2003;51(5):267–273. PubMed

Santiago T, et al. Epicardial radiofrequency applications: in vitro and in vivo studies on human atrial myocardium. Eur J Cardiothorac Surg. 2003;24(4):481–486. discussion 486. PubMed

Thomas SP, et al. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg. 2003;75(2):543–548. PubMed

van Brakel TJ, et al. Evaluation of epicardial microwave ablation lesions: histology versus electrophysiology. Ann Thorac Surg. 2004;78(4):1397–1402. discussion 1397–1402. PubMed

Deneke T, et al. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J. 2005;26(17):1797–1803. PubMed

Schuessler RB, et al. Animal studies of epicardial atrial ablation. Heart Rhythm. 2009;6(12 Suppl):S41–S45. PubMed PMC

Melby SJ, et al. Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output. J Thorac Cardiovasc Surg. 2006;132(2):355–360. PubMed

Gammie JS, et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2008;85(3):909–914. PubMed

Damiano RJ, Jr, et al. The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141(1):113–121. PubMed PMC

Ad N, et al. Impact of follow-up on the success rate of the cryosurgical maze procedure in patients with rheumatic heart disease and enlarged atria. J Thorac Cardiovasc Surg. 2006;131(5):1073–1079. PubMed

Gammie JS, et al. A multi-institutional experience with the CryoMaze procedure. Ann Thorac Surg. 2005;80(3):876–880. discussion 880. PubMed

Gaynor SL, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128(4):535–542. PubMed

Weimar T, et al. The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011;31(1):47–54. PubMed PMC

Henn MC, et al. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2015;150(5):1168–1176. 1178 e1–2. PubMed PMC

Lall SC, et al. The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg. 2007;133(2):389–396. PubMed

Voeller RK, et al. Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg. 2008;135(4):870–877. PubMed

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755–759. PubMed

McCarthy PM, et al. The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg. 2000;12(1):25–29. PubMed

Stulak JM, et al. Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success? Ann Thorac Surg. 2007;83(4):1319–1324. PubMed

Buber J, et al. Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol. 2011;58(15):1614–1621. PubMed

Holmes DR, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–542. PubMed

Holmes DR, Jr, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus longterm warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12. PubMed

Gillinov AM, Pettersson G, Cosgrove DM. Stapled excision of the left atrial appendage. J Thorac Cardiovasc Surg. 2005;129(3):679–680. PubMed

Healey JS, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150(2):288–293. PubMed

Romanov A, et al. Effect of left atrial appendage excision on procedure outcome in patients with persistent atrial fibrillation undergoing surgical ablation. Heart Rhythm. 2016;13(9):1803–1809. PubMed

Kanderian AS, et al. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52(11):924–929. PubMed

Lee R, et al. A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: internal ligation, stapled excision, and surgical excision. J Thorac Cardiovasc Surg. 2016;152(4):1075–1080. PubMed

Bartus K, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62(2):108–118. PubMed

Price MJ, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol. 2014;64(6):565–572. PubMed PMC

Pillarisetti J, et al. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015;12(7):1501–1507. PubMed

Ailawadi G, et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011;142(5):1002–1009, 1009.e1. PubMed

Emmert MY, et al. Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg. 2014;45(1):126–131. PubMed

Lee R, et al. Late neurologic events after surgery for atrial fibrillation: rare but relevant. Ann Thorac Surg. 2013;95(1):126–131. discussion 131–132. PubMed

Badhwar V, et al. The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: a report of the Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg. 2016;101(6):2265–2271. PubMed

Abreu Filho CA, et al. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation. 2005;112(9 Suppl):I20–I25. PubMed

Doukas G, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA. 2005;294(18):2323–2329. PubMed

Blomstrom-Lundqvist C, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF) Eur Heart J. 2007;28(23):2902–2908. PubMed

Chevalier P, et al. Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR) Arch Cardiovasc Dis. 2009;102(11):769–775. PubMed

Cheng DC, et al. Surgical ablation for atrial fibrillation in cardiac surgery: a meta-analysis and systematic review. Innovations (Phila) 2010;5(2):84–96. PubMed

Budera P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33(21):2644–2652. PubMed PMC

Phan K, et al. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart. 2014;100(9):722–730. PubMed

Gillinov AM, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372(15):1399–1409. PubMed PMC

Rankin JS, et al. The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery. Ann Thorac Surg. 2013;95(4):1484–1490. PubMed

Louagie Y, et al. Improved patient survival with concomitant Cox Maze III procedure compared with heart surgery alone. Ann Thorac Surg. 2009;87(2):440–446. PubMed

Chiappini B, Di Bartolomeo R, Marinelli G. Radiofrequency ablation for atrial fibrillation: different approaches. Asian Cardiovasc Thorac Ann. 2004;12(3):272–277. PubMed

Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131(5):1029–1035. PubMed

Edgerton JR, Jackman WM, Mack MJ. A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set. Ann Thorac Surg. 2009;88(5):1655–1657. PubMed

Edgerton JR, et al. Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the “Dallas” lesion set. Heart Rhythm. 2009;6(12 Suppl):S64–S70. PubMed

Lockwood D, et al. Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: techniques for assessing conduction block across surgical lesions. Heart Rhythm. 2009;6(12 Suppl):S50–S63. PubMed

Malaisrie SC, et al. Atrial fibrillation ablation in patients undergoing aortic valve replacement. J Heart Valve Dis. 2012;21(3):350–357. PubMed

Cherniavsky A, et al. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders. Interact Cardiovasc Thorac Surg. 2014;18(6):727–731. PubMed

Yoo JS, et al. Impact of concomitant surgical atrial fibrillation ablation in patients undergoing aortic valve replacement. Circ J. 2014;78(6):1364–1371. PubMed

Damiano RJ, Jr, et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg. 2003;126(6):2016–2021. PubMed

Akpinar B, et al. Combined off-pump coronary artery bypass grafting surgery and ablative therapy for atrial fibrillation: early and mid-term results. Ann Thorac Surg. 2006;81(4):1332–1337. PubMed

Geidel S, et al. Permanent atrial fibrillation ablation surgery in CABG and aortic valve patients is at least as effective as in mitral valve disease. Thorac Cardiovasc Surg. 2006;54(2):91–95. PubMed

Geidel S, et al. Persistent atrial fibrillation ablation concomitant to coronary surgery. Thorac Cardiovasc Surg. 2011;59(4):207–212. PubMed

Krul SP, et al. Navigating the mini-maze: systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol. 2013;166(1):132–140. PubMed

Kainuma S, et al. Dilated left atrium as a predictor of late outcome after pulmonary vein isolation concomitant with aortic valve replacement and/or coronary artery bypass grafting. Eur J Cardiothorac Surg. 2015;48(5):765–777. discussion 777. PubMed

Cox JL, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101(4):569–583. PubMed

Rodriguez E, et al. Minimally invasive bi-atrial CryoMaze operation for atrial fibrillation. Oper Tech Thorac Cardiovasc Surg. 2009;14(3):208–223.

Wolf RK, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802. PubMed

Edgerton JR, et al. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. Ann Thorac Surg. 2008;86(1):35–38. discussion 39. PubMed

Edgerton JR, et al. Minimally invasive surgical ablation of atrial fibrillation: sixmonth results. J Thorac Cardiovasc Surg. 2009;138(1):109–113. discussion 114. PubMed

Beyer E, Lee R, Lam BK. Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg. 2009;137(3):521–526. PubMed

Kearney K, et al. A systematic review of surgical ablation versus catheter ablation for atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):15–29. PubMed PMC

Ad N, et al. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg. 2012;144(5):1051–1060. PubMed

Driessen AH, et al. Electrophysiologically guided thoracoscopic surgery for advanced atrial fibrillation: 5-year follow-up. J Am Coll Cardiol. 2017;69(13):1753–1754. PubMed

Khargi K, et al. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005;27(2):258–265. PubMed

Wazni OM, et al. Atrial arrhythmias after surgical maze: findings during catheter ablation. J Am Coll Cardiol. 2006;48(7):1405–1409. PubMed

Magnano AR, et al. Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2006;17(4):366–373. PubMed

McElderry HT, et al. Proarrhythmic aspects of atrial fibrillation surgery: mechanisms of postoperative macroreentrant tachycardias. Circulation. 2008;117(2):155–162. PubMed

McCarthy PM, et al. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovasc Surg. 2010;139(4):860–867. PubMed

Zeng Y, et al. Recurrent atrial arrhythmia after minimally invasive pulmonary vein isolation for atrial fibrillation. Ann Thorac Surg. 2010;90(2):510–515. PubMed

Lee R, et al. Surgical treatment for isolated atrial fibrillation: minimally invasive vs. classic cut and sew maze. Innovations (Phila) 2011;6(6):373–377. PubMed

Edgerton JR, et al. Totally thoracoscopic surgical ablation or catheter ablation of atrial fibrillation: a systematic review and preliminary meta-analysis. Card Electrophysiol Clin. 2012;4(3):413–423. PubMed

Edgerton Z, et al. Hybrid procedure (endo/epicardial) versus standard manual ablation in patients undergoing ablation of long-standing persistent atrial fibrillation: results from a single center. J Cardiovasc Electrophysiol. 2016;27(5):524–530. PubMed

Wright M, et al. State of the art: catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(6):583–592. PubMed

Sueda T, et al. Long-term results after the box pulmonary vein isolation procedure for chronic atrial fibrillation in mitral valve surgery. Ann Thorac Cardiovasc Surg. 2012;18(2):101–108. PubMed

Maagh P, et al. Pulmonary vein isolation in 2012: is it necessary to perform a time consuming electrophysical mapping or should we focus on rapid and safe therapies? A retrospective analysis of different ablation tools. Int J Med Sci. 2013;10(1):24–33. PubMed PMC

Bisleri G, et al. The need of a hybrid approach for the treatment of atrial fibrillation. Heart Surg Forum. 2005;8(5):E326–E330. PubMed

Nitta T. Surgery for atrial fibrillation: a worldwide review. Semin Thorac Cardiovasc Surg. 2007;19(1):3–8. PubMed

Byrne JG, et al. Hybrid cardiovascular procedures. JACC Cardiovasc Interv. 2008;1(5):459–468. PubMed

La Meir M, et al. The hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source. J Cardiothorac Surg. 2012;7:71. PubMed PMC

Prasad SM, et al. Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg. 2002;124(4):708–713. PubMed

Kiser AC, et al. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13(5):E317–E321. PubMed

Kiser AC, et al. Simultaneous catheter and epicardial ablations enable a comprehensive atrial fibrillation procedure. Innovations (Phila) 2011;6(4):243–247. PubMed

Natale A, et al. Hybrid procedure (endo/epicardial) versus standard manual ablation in patients undergoing ablation of long-standing persistent atrial fibrillation: results from a single center [abstract] Heart Rhythm. 2011;8(Suppl 5):S79. PubMed

Belden W, Moraca R. The convergent procedure for AF: experience at Allegheny General Hospital. EP Lab Digest. 2013;13(5)

Civello KC, Smith CA, Boedefeld W. Combined endocardial and epicardial ablation for symptomatic atrial fibrillation: single center experience in 100+ consecutive patients. Journal of Innovations in Cardiac Rhythm Management. 2013:1–7.

Robinson M, et al. Maximizing ablation, limiting invasiveness, and being realistic about atrial fibrillation: the convergent hybrid ablation procedure for advanced AF. EP Lab Digest. 2013;13(6)

Thosani AJ, et al. Closed chest convergent epicardial-endocardial ablation of non-paroxysmal atrial fibrillation—a case series and literature review. Arrhythm Electrophysiol Rev. 2013;2(1):65–68. PubMed PMC

Je HG, Shuman DJ, Ad N. A systematic review of minimally invasive surgical treatment for atrial fibrillation: a comparison of the Cox-Maze procedure, beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy. Eur J Cardiothorac Surg. 2015;48(4):531–540. discussion 540–541. PubMed

Farina E, et al. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand. 1997;96(5):310–316. PubMed

De Groot JC, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52(3):335–341. PubMed

Sacco RL, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. PubMed PMC

Wardlaw JM, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. PubMed PMC

Wang X, et al. Early recurrences after paroxysmal atrial fibrillation ablation: when is the proper timing for reablation? Pacing Clin Electrophysiol. 2011;34(6):709–716. PubMed

Healey JS, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129. PubMed

Mantovan R, et al. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial. Can J Cardiol. 2013;29(10):1211–1217. PubMed

Suman-Horduna I, et al. Quality of life and functional capacity in patients with atrial fibrillation and congestive HF. J Am Coll Cardiol. 2013;61(4):455–460. PubMed

Arya A, et al. Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2007;30(4):458–462. PubMed

Glotzer TV, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) Circulation. 2003;107(12):1614–1619. PubMed

Di Biase L, et al. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Heart Rhythm. 2015;12(6):1162–1168. PubMed

Wu RC, et al. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2002;13(8):819–821. PubMed

Natale A, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898–1904. PubMed

Black-Maier E, et al. Risk of atrioesophageal fistula formation with contact-force sensing catheters. Heart Rhythm. 2017:30452–30456. PubMed

Thygesen K, et al. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173–2195. PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial

Nature medicine. 2024 Aug ; 30 (8) : 2303-2310. [epub] 20240517

Nat Med
ISSN 1546-170X | 1078-8956
Zdroj

Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study

Europace. 2024 Mar 01 ; 26 (3) : .

ISSN 1532-2092 | 1099-5129
Zdroj

Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of 'ground truth'

Europace. 2023 Nov 02 ; 25 (11) : .